Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,Nicotine addiction,0.766409166546531,1.766931860929224,0.0,0.13910844135314573,0.09,15/23,11.69%,GABRB2;GRIA2;GRIN2B;CACNA1B;GABRG1;GRIA1;GRIN3B;GRIN2D;GABRA5;CACNA1A;GRIN2A;GABRG3;SLC17A7;GRIN3A;GRIA3
prerank,Renin-angiotensin system,0.7649086440650259,1.6846934452657287,0.023255813953488372,0.2503951944356623,0.31,10/21,15.56%,CPA3;CTSG;CMA1;REN;AGT;AGTR2;AGTR1;MME;ACE2;ENPEP
prerank,Glycosphingolipid biosynthesis,0.616127904202141,1.6750520817298074,0.0,0.19011486984929918,0.34,4/42,3.19%,FUT3;FUT9;B3GNT3;ST6GALNAC5
prerank,Circadian entrainment,0.5590643849461053,1.6423592159179297,0.0,0.18084097375908947,0.42,30/83,16.49%,ADCYAP1;GRIA2;GRIN2B;NOS1;NOS1AP;GNG10;CACNA1G;KCNJ6;PRKG2;GRIA1;GNG8;ADCY6;GRIN2D;FOS;ADCY5;PER3;GRIN2A;ADCY4;GRIA3;GUCY1B1;CACNA1I;CALML6;ADCY7;CACNA1C;PLCB3;KCNJ5;ADCY1;CACNA1H;CACNA1D;ADCY3
prerank,Vitamin digestion and absorption,-0.749742762342708,-1.5691856587452957,0.05,1.0,0.7,6/19,8.77%,RBP2;SLC23A1;SLC19A3;FOLH1;SLC19A2;SLC52A3
prerank,Mannose type O-glycan biosynthesis,0.644802276106516,1.5171156916329678,0.10810810810810811,0.5174834018337021,0.83,1/22,0.11%,FUT9
prerank,Fatty acid elongation,-0.6696578898264112,-1.511978614349862,0.046875,1.0,0.89,2/27,1.88%,ELOVL3;ACOT1
prerank,Ubiquinone and other terpenoid-quinone biosynthesis,-0.8351023475662911,-1.499017943259829,0.02,0.9770755001348502,0.93,1/10,0.28%,HPD
prerank,Ribosome,-0.5307650436644578,-1.4761918029952945,0.012987012987012988,1.0,0.97,85/129,30.91%,RPS26;RPL17;RPL3L;RPL15;MRPS17;RPL18A;RPL10;RPL8;RPL18;RPS5;RPS18;RPS14;RPL7A;RPL19;RPS16;RPL12;RPS4X;RPS3;MRPL12;RPS2;RPL13;RPS7;RPL29;MRPL14;MRPL11;RPL14;RPSA;RPS9;MRPL23;RPL6;RPL10A;RPS13;RPS19;RPS27A;RPL5;RPS12;RSL24D1;MRPS15;FAU;RPLP0;RPS3A;MRPL4;UBA52;RPL26;RPL24;RPLP1;RPL22;RPS15A;RPS8;RPS15;RPL28;MRPS12;RPL3;RPL13A;RPL32;RPL9;MRPS7;RPS11;MRPS6;RPL11;MRPL10;RPS27L;RPS6;RPS24;RPL23A;MRPL28;MRPL27;MRPL36;RPL35A;RPL23;MRPS5;RPL4;RPL7;RPL26L1;RPL27A;RPL36AL;MRPL3;MRPL17;MRPL22;RPS25;MRPL20;MRPL21;MRPL35;RPLP2;MRPS2
prerank,Serotonergic synapse,0.45486446647730766,1.4556408414384683,0.02702702702702703,0.7604594793971967,0.95,22/88,14.23%,DDC;GABRB2;JMJD7-PLA2G4B;HTR3C;ALOX15B;HTR2A;GNG10;CACNA1B;KCNJ6;CYP2J2;GNG8;HTR1F;ALOX12B;SLC18A1;HTR2B;ADCY5;CACNA1A;ALOX5;CYP2C8;CACNA1C;PLCB3;KCNJ5
prerank,Synaptic vesicle cycle,0.4759282585407777,1.3959374182909619,0.03571428571428571,0.9618355087846078,0.98,15/63,13.45%,SLC18A3;SYT1;SLC6A7;ATP6V0D2;SLC6A1;CACNA1B;UNC13A;SNAP25;DNM1;SLC18A1;CACNA1A;SLC17A7;SLC1A3;DNM3;TCIRG1
prerank,Salivary secretion,0.4507740528393747,1.3722810444816091,0.034482758620689655,1.0,1.0,28/71,19.03%,CST5;CST2;NOS1;ADRA1D;CST1;CST4;SLC4A2;ATP1A2;PRKG2;ADRA1A;ADCY6;ADCY5;ADCY4;ADRB2;GUCY1B1;CALML6;ADCY7;PRH2;ATP1A3;PLCB3;CHRM3;ADCY1;BST1;ADCY3;ATP1A4;GUCY1A2;ATP2B4;GUCY1A1
prerank,Amyotrophic lateral sclerosis (ALS),0.47901048211649466,1.3498249823347128,0.05555555555555555,1.0,1.0,8/50,10.75%,NEFM;GRIA2;GRIN2B;NOS1;GRIA1;TOMM40L;GRIN2D;GRIN2A
prerank,Proteasome,-0.5466415455789378,-1.345154203579113,0.1,1.0,1.0,29/45,33.61%,PSMB11;PSMA8;PSMB6;PSMD8;PSMB3;PSMB9;PSMB1;PSMB10;PSME1;PSMB5;POMP;IFNG;PSMD13;PSMF1;PSMB2;PSMB8;PSME4;PSMA7;ADRM1;PSMC3;PSMD4;PSME2;PSMA3;PSMD3;PSMC4;PSMB7;PSMD11;PSMA5;PSMA1
prerank,Biosynthesis of unsaturated fatty acids,-0.6305827166975927,-1.3379331152172254,0.09090909090909091,1.0,1.0,2/27,1.88%,ELOVL3;ACOT1
prerank,Taurine and hypotaurine metabolism,0.7130624566159047,1.3334049132805914,0.13636363636363635,1.0,1.0,6/7,24.82%,BAAT;CSAD;ADO;GGT6;CDO1;GGT5
prerank,Systemic lupus erythematosus,0.4598211960311342,1.321266872095005,0.1,1.0,1.0,8/51,10.75%,C8B;CTSG;GRIN2B;FCGR3B;C9;C6;ELANE;GRIN2A
prerank,Protein digestion and absorption,0.4740347394629224,1.31838046940865,0.10344827586206896,1.0,1.0,24/74,10.53%,CPA3;SLC8A2;PRSS1;COL11A1;COL1A1;COL3A1;COL6A5;ATP1A2;CPB2;DPP4;COL10A1;COL22A1;COL13A1;COL1A2;COL4A6;COL21A1;COL6A3;SLC15A1;COL5A2;XPNPEP2;COL24A1;COL5A1;SLC36A1;COL7A1
prerank,"Parathyroid hormone synthesis, secretion and action",0.44081765663961825,1.3152944889024967,0.045454545454545456,0.9619883752036772,1.0,22/95,16.49%,SOST;CASR;CYP24A1;MMP24;SLC34A2;RXRG;PDE4C;SLC34A3;ADCY6;BGLAP;FOS;ADCY5;PTH1R;ADCY4;TNFSF11;ADCY7;MMP14;PLCB3;CREB3L1;ADCY1;ATF6B;ADCY3
prerank,Dopaminergic synapse,0.4302326734401292,1.3129540840762464,0.06666666666666667,0.9032112370714963,1.0,26/114,14.65%,DDC;CALY;GRIA2;GRIN2B;GNG10;CACNA1B;LRTOMT;KCNJ6;GRIA1;GNG8;KIF5C;PPP2R2C;PPP1R1B;SLC18A1;FOS;ADCY5;CACNA1A;GRIN2A;KIF5A;GRIA3;CALML6;CACNA1C;MAPK11;PLCB3;KCNJ5;CREB3L1
prerank,Renin secretion,0.43223197850002665,1.3116413777145097,0.09090909090909091,0.851343661081252,1.0,19/60,13.79%,ADCYAP1;REN;PRKG2;AGT;NPPA;ADCY6;KCNJ2;ADCY5;PDE3B;PDE1C;EDN1;EDNRA;ADRB2;AGTR1;GUCY1B1;PDE3A;CALML6;CACNA1C;PLCB3
prerank,Vascular smooth muscle contraction,0.41272093746727895,1.3095953066412844,0.0,0.8068289598482453,1.0,31/116,14.51%,CALCA;CYP4A11;NPPB;JMJD7-PLA2G4B;ADRA1D;CALCB;PLA2G3;AGT;MYLK3;MYLK2;PLA2G10;NPPA;ADRA1A;ADCY6;NPPC;KCNMB1;ADCY5;ADORA2B;ACTA2;EDN1;MYH11;ADCY4;EDNRA;AGTR1;GUCY1B1;KCNMB4;CALML6;ADCY7;CACNA1C;PLCB3;MYLK4
prerank,Pentose phosphate pathway,-0.5814414641861816,-1.305540114221852,0.16666666666666666,1.0,1.0,13/26,28.15%,FBP2;ALDOA;PGLS;ALDOC;TALDO1;TKT;PFKP;RBKS;PRPS2;PGM1;PGD;RGN;FBP1
prerank,Glutamatergic synapse,0.42078159987931785,1.3028466080034988,0.047619047619047616,0.7855535511707054,1.0,26/96,13.79%,JMJD7-PLA2G4B;GRIA2;SHANK1;GRIN2B;GRM7;GNG10;GRM4;GRIA1;GRM6;SHANK3;GNG8;GRIN3B;ADCY6;GRIN2D;ADCY5;CACNA1A;GRIN2A;ADCY4;SLC17A7;SLC1A3;GRIN3A;GRIA3;GRIK3;ADCY7;CACNA1C;PLCB3
prerank,Inflammatory bowel disease (IBD),-0.5325503181028398,-1.3026636994661487,0.11428571428571428,1.0,1.0,18/58,17.69%,IL13;IL6;IL12RB2;IL23A;IL1A;TNF;IL2;IL1B;NFATC1;TGFB1;HLA-DQA1;IL12RB1;HLA-DQB1;IL18RAP;HLA-DQA2;IL12B;IL21R;HLA-DOB
prerank,Steroid biosynthesis,0.5866503360113057,1.2943845915223622,0.14285714285714285,0.7735974988583273,1.0,9/18,23.10%,CYP24A1;CEL;LIPA;HSD17B7;CYP2R1;SQLE;SOAT1;CYP27B1;LSS
prerank,Malaria,-0.5456306864066044,-1.2854996546262956,0.14516129032258066,1.0,1.0,13/45,11.66%,CSF3;CCL2;IL6;HBA2;CR1;HBB;HBA1;THBS1;CXCL8;TNF;IL1B;THBS2;TGFB1
prerank,Arachidonic acid metabolism,0.48080289498819023,1.2834168591383353,0.07317073170731707,0.7834001697256102,1.0,11/45,13.09%,CYP4A11;JMJD7-PLA2G4B;GPX2;PLA2G3;ALOX15B;CYP2J2;PLA2G10;ALOX12B;ALOX5;CYP2E1;CYP2C8
prerank,JAK-STAT signaling pathway,-0.4612508679632778,-1.2796527494528094,0.07792207792207792,1.0,1.0,25/129,16.32%,IL13;IL13RA2;EPO;CSF3;TSLP;IL11;IL24;IL6;CDKN1A;LIF;IL12RB2;IL23A;IL2;IL2RA;PIM1;IL12RB1;MYC;CNTFR;IL3RA;SOCS3;MCL1;CCND1;IL12B;IL20RA;IL21R
prerank,Platelet activation,0.3971691888033717,1.2759777718483691,0.09090909090909091,0.7810938981979133,1.0,41/112,26.12%,JMJD7-PLA2G4B;COL1A1;COL3A1;ITGA2;PRKG2;MYLK3;P2RY12;MYLK2;COL1A2;ADCY6;P2RX1;ADCY5;TBXA2R;GP6;ADCY4;GUCY1B1;ADCY7;APBB1IP;MAPK11;PLCB3;MYLK4;PIK3R6;ADCY1;VWF;ADCY3;GUCY1A2;PTGIR;PIK3R5;GUCY1A1;F2R;FYN;FCER1G;RASGRP1;TBXAS1;ADCY9;ARHGEF1;NOS3;ROCK2;MAPK1;MAPK12;MYLK
prerank,Parkinson disease,-0.45346644342358583,-1.2619152668702176,0.1038961038961039,1.0,1.0,69/121,36.00%,DRD1;COX6B2;NDUFA7;COX4I1;SLC25A4;NDUFC2;NDUFA4L2;CYCS;ATP5MC2;ATP5MC1;NDUFS8;NDUFA12;COX7A2L;COX8A;NDUFB11;NDUFB7;NDUFB9;SLC25A6;ATP5PO;SLC6A3;COX4I2;UBB;TH;COX5A;SLC25A5;COX6A1;VDAC3;UQCRFS1;PARK7;VDAC2;NDUFB10;NDUFAB1;COX5B;NDUFB5;VDAC1;CYC1;UQCRH;NDUFB8;ATP5PD;ATP5MC3;SNCA;ATP5F1C;CASP3;HTRA2;NDUFS6;NDUFA10;SDHB;NDUFS4;UQCRB;ATP5F1A;NDUFV2;UQCRC1;APAF1;NDUFA2;NDUFS7;NDUFA11;UBE2J2;GNAL;UBE2L6;NDUFA4;GNAI3;NDUFA6;NDUFA5;NDUFS3;PPIF;SDHC;UQCRC2;ATP5PF;NDUFB2
prerank,Pathogenic Escherichia coli infection,-0.5015118566353272,-1.2356050184683947,0.1780821917808219,1.0,1.0,29/48,35.66%,TUBA3D;TUBB8;TUBB2A;TUBA1B;ACTG1;TUBB4B;KRT18;TUBA1C;EZR;ACTB;ARPC5L;NCL;TUBA4A;TUBB6;YWHAQ;CLDN1;TUBA1A;WASL;OCLN;ARPC3;YWHAZ;RHOA;HCLS1;ARPC5;CTTN;ARPC2;ABL1;CTNNB1;TUBB
prerank,Neuroactive ligand-receptor interaction,0.3510882914955497,1.2177410746389055,0.0,1.0,1.0,67/218,12.08%,ADCYAP1;GRP;CALCA;GABRB2;CTSG;SST;MC4R;APLN;NMU;GRIA2;P2RX6;S1PR5;GRIN2B;KISS1R;ADRA1D;GRM7;KNG1;PRSS1;CALCB;LPAR4;KISS1;PTGER1;UTS2R;HTR2A;PTGER3;GLRB;GABRG1;GRM4;BDKRB1;GRIA1;FPR2;GRM6;AGT;GNRHR;HCRT;GRIN3B;ADRA1A;CRHR2;SSTR1;FPR3;GRIN2D;AGTR2;ADRA2C;HTR1F;GABRA5;HRH2;P2RX1;LHB;HTR2B;ADORA2B;SCT;PTH1R;GCGR;TBXA2R;GRIN2A;GAL;C3AR1;GABRG3;EDN1;HRH1;EDNRA;GRIN3A;GRIA3;ADRB2;AGTR1;GRIK3;PRLR
prerank,Porphyrin and chlorophyll metabolism,-0.5356882972128627,-1.2095615484062068,0.22641509433962265,1.0,1.0,1/24,0.07%,ALAS2
prerank,Morphine addiction,0.3796808147424074,1.1784589700221917,0.25,1.0,1.0,17/71,12.75%,GABRB2;GNG10;CACNA1B;KCNJ6;GABRG1;PDE4C;GNG8;ADCY6;GABRA5;ADCY5;PDE3B;CACNA1A;PDE1C;GABRG3;ADCY4;PDE3A;ADCY7
prerank,Hematopoietic cell lineage,-0.4358732073297077,-1.1735900878613863,0.2,1.0,1.0,29/87,19.86%,EPO;CSF3;IL11;IL6;CR1;IL1R2;IL1A;TNF;MS4A1;FCER2;IL1B;IL2RA;GP5;HLA-DQA1;CD3G;CD37;CD3D;IL3RA;ITGA2B;HLA-DQB1;HLA-DQA2;CD19;CD1C;CD22;HLA-DOB;ITGA5;KIT;HLA-DRA;TFRC
prerank,Gastric acid secretion,0.3936292689584957,1.1732078765106169,0.1875,1.0,1.0,18/65,15.46%,CFTR;SST;SLC4A2;ATP1A2;MYLK3;MYLK2;ADCY6;KCNJ2;HRH2;ADCY5;ADCY4;CALML6;ADCY7;ATP1A3;PLCB3;CHRM3;MYLK4;ADCY1
prerank,Ferroptosis,-0.49653701937870387,-1.1719478634963987,0.2982456140350877,1.0,1.0,13/38,24.67%,MAP1LC3C;ALOX15;MAP1LC3A;GCLC;MAP1LC3B;GPX4;SAT1;TFRC;VDAC3;VDAC2;SLC7A11;ATG5;SLC3A2
prerank,Cholesterol metabolism,0.4656039634705543,1.1698264379562993,0.23076923076923078,1.0,1.0,10/40,15.23%,PCSK9;STAR;APOE;LPL;APOC1;ANGPTL8;ANGPTL3;NPC1;LIPG;LIPA
prerank,Apelin signaling pathway,0.35544025227767106,1.1612837492413532,0.08,1.0,1.0,27/124,17.64%,SLC8A2;APLN;SPP1;PRKAG3;NOS1;GNG10;MYLK3;MYLK2;GNG8;ADCY6;ADCY5;PDE3B;PRKAG1;ACTA2;ADCY4;AGTR1;CALML6;ADCY7;KLF2;PLCB3;MYLK4;PIK3R6;ADCY1;NOS2;ADCY3;APLNR;PRKAB2
prerank,Non-homologous end-joining,0.5387959466150883,1.1600244412668792,0.30612244897959184,1.0,1.0,1/13,1.89%,NHEJ1
prerank,Butanoate metabolism,-0.5300493938909325,-1.1589388050906428,0.34782608695652173,1.0,1.0,5/24,10.40%,ACSM2A;ACSM2B;ACSM6;HMGCS1;ACAT2
prerank,Arrhythmogenic right ventricular cardiomyopathy (ARVC),-0.4417553130811518,-1.1563731078398773,0.22413793103448276,1.0,1.0,16/64,19.59%,CACNA1S;ITGB7;SGCG;CTNNA3;LMNA;CACNB2;ACTG1;GJA1;CACNA2D3;ITGA2B;RYR2;JUP;ITGA5;SGCD;ACTB;EMD
prerank,ABC transporters,0.4123712583304522,1.1559612305501132,0.21212121212121213,1.0,1.0,18/41,20.40%,CFTR;ABCB6;ABCA12;ABCB1;DEFB1;ABCG2;ABCA4;ABCC10;ABCC9;ABCA7;ABCA9;ABCD2;ABCB10;ABCA5;ABCG5;ABCC3;ABCA8;ABCA10
prerank,Estrogen signaling pathway,0.38704976310046696,1.1524651735735314,0.23076923076923078,1.0,1.0,23/106,16.49%,KRT16;KRT15;KRT17;KCNJ6;TFF1;ADCY6;SHC4;KRT19;FOS;ADCY5;ADCY4;KRT14;TGFA;CALML6;ADCY7;PLCB3;KCNJ5;MMP2;CREB3L1;JUN;ADCY1;ATF6B;ADCY3
prerank,Oxidative phosphorylation,-0.44097871856830273,-1.1487744692504613,0.22857142857142856,1.0,1.0,67/114,36.00%,ATP4A;ATP4B;COX6B2;ATP12A;ATP6V1C2;ATP6V0E2;NDUFA7;COX4I1;NDUFC2;NDUFA4L2;ATP5MC2;ATP5MC1;NDUFS8;NDUFA12;COX7A2L;COX8A;NDUFB11;ATP6V1E2;NDUFB7;NDUFB9;ATP5PO;LHPP;COX4I2;ATP6V0E1;COX5A;COX6A1;UQCRFS1;ATP6V0B;NDUFB10;NDUFAB1;COX5B;NDUFB5;CYC1;UQCRH;ATP6V0D1;NDUFB8;ATP5PD;ATP6V1F;ATP5MC3;ATP6V1C1;ATP5F1C;ATP5MG;ATP6V1G1;NDUFS6;NDUFA10;SDHB;NDUFS4;PPA1;UQCRB;ATP6V1D;ATP5F1A;NDUFV2;UQCRC1;NDUFA2;NDUFS7;NDUFA11;ATP6V1G2;NDUFA4;NDUFA6;NDUFA5;NDUFS3;PPA2;SDHC;UQCRC2;COX10;ATP5PF;NDUFB2
prerank,Histidine metabolism,0.5274999576529155,1.1437843235644531,0.2558139534883721,1.0,1.0,7/21,13.85%,HDC;HAL;CNDP1;ALDH3B1;ALDH3A1;HNMT;ALDH1A3
prerank,p53 signaling pathway,-0.4313286415193903,-1.14364641588481,0.3235294117647059,1.0,1.0,20/71,21.10%,RPRM;SERPINE1;GADD45A;CDKN1A;GADD45B;THBS1;CCNB2;CYCS;TNFRSF10B;SESN2;SIVA1;CCND1;DDB2;BBC3;RRM2B;CCNE2;PPM1D;RRM2;GTSE1;BID
prerank,"Glycine, serine and threonine metabolism",-0.4773813381152941,-1.1401080659186797,0.2542372881355932,1.0,1.0,13/34,27.70%,ALAS2;GAMT;GCAT;AMT;PSPH;MAOA;CBS;GNMT;SDSL;GCSH;GLDC;SDS;CTH
prerank,Fructose and mannose metabolism,-0.49956706922573435,-1.1314253489039392,0.328125,1.0,1.0,9/30,17.16%,FBP2;AKR1B10;ALDOA;HK2;ALDOC;PFKFB3;TPI1;PFKFB2;PMM1
prerank,Regulation of lipolysis in adipocytes,-0.4510040073120444,-1.1303740679949412,0.30985915492957744,1.0,1.0,2/48,1.35%,NPY;CGA
prerank,Wnt signaling pathway,0.3423305524107536,1.128693900298862,0.2222222222222222,1.0,1.0,27/142,15.92%,SOST;DKK2;LGR5;SFRP2;MMP7;NKD2;LGR6;RSPO4;RSPO3;PRICKLE4;FZD8;WNT9A;VANGL2;WNT3;WNT1;WNT5A;WNT6;WNT10B;WNT16;RSPO1;PLCB3;FRAT1;CSNK1E;WNT2;JUN;SFRP1;WNT5B
prerank,Complement and coagulation cascades,0.37014209588995206,1.127551229523519,0.2413793103448276,1.0,1.0,28/66,21.28%,C8B;KNG1;C4BPA;C9;CPB2;BDKRB1;SERPINC1;C6;PROS1;VSIG4;C3AR1;SERPIND1;F5;CFI;ITGB2;C7;A2M;CFH;F2RL2;VWF;PROC;ITGAM;SERPINA1;SERPINF2;PLAU;F2R;C1S;C5
prerank,Pancreatic secretion,0.38450603177865134,1.1269935627915544,0.13333333333333333,1.0,1.0,24/77,16.85%,CFTR;CPA3;PRSS1;CEL;RAB27B;PLA2G3;SLC4A2;ATP1A2;SLC26A3;CPB2;PLA2G10;ADCY6;ADCY5;SCT;ADCY4;ADCY7;ATP1A3;PLCB3;CHRM3;TPCN2;ADCY1;BST1;ADCY3;RAB3D
prerank,Spliceosome,-0.4038340824857032,-1.1196860075962562,0.19718309859154928,1.0,1.0,70/127,39.53%,HSPA1A;HSPA6;DHX38;RBM8A;EIF4A3;HSPA1B;BUD31;PRPF40B;HSPA8;U2AF1L4;LSM7;SF3B5;XAB2;SNRPC;TXNL4A;SNRPB;HSPA2;MAGOH;SNRPD2;SF3B4;LSM3;LSM2;DDX39B;SNRNP40;SNRPD1;SNU13;USP39;BCAS2;SNRPD3;PHF5A;LSM4;CWC15;PPIH;PRPF4;DHX15;RBMXL1;PRPF18;SNRPB2;TRA2A;WBP11;RBMX;PUF60;SNW1;HNRNPU;SNRPA;PPIE;HNRNPK;PRPF31;PRPF38A;HNRNPA1;DDX5;CCDC12;SF3B6;SF3A2;SNRNP27;ZMAT2;THOC3;CDC40;LSM6;CTNNBL1;SNRPG;SRSF2;TRA2B;PPIL1;LSM8;RP9;SNRPE;CDC5L;LSM5;SF3A1
prerank,Amoebiasis,0.37095285437790365,1.119511361956796,0.1794871794871795,1.0,1.0,9/86,7.48%,C8B;CTSG;FN1;COL1A1;COL3A1;C9;LAMB3;COL1A2;COL4A6
prerank,Metabolism of xenobiotics by cytochrome P450,0.4272133004578436,1.1070335553020534,0.26666666666666666,1.0,1.0,10/35,13.85%,DHDH;CYP1B1;HSD11B1;UGT2A1;AKR7A3;CYP2S1;ALDH3B1;ALDH3A1;CYP2E1;ALDH1A3
prerank,Intestinal immune network for IgA production,-0.46154404596245674,-1.0976042490888636,0.359375,1.0,1.0,19/44,25.48%,ITGB7;IL6;ICOSLG;IL2;CD28;TGFB1;HLA-DQA1;TNFSF13;HLA-DQB1;CD40LG;HLA-DQA2;HLA-DOB;HLA-DRA;MAP3K14;HLA-DRB5;TNFRSF13B;CCR10;CD40;HLA-DPB1
prerank,Phototransduction,-0.5602601451082402,-1.095636524703363,0.375,1.0,1.0,8/18,15.01%,RCVRN;GNAT1;GRK1;GUCY2D;SLC24A1;CNGA1;PDE6G;PDE6B
prerank,Cytokine-cytokine receptor interaction,-0.3722815596736975,-1.0935793132981004,0.2564102564102564,1.0,1.0,53/236,15.65%,IL13;GDF3;IL13RA2;CXCR5;EPO;IL1RL1;PPBP;CSF3;TNFRSF12A;TSLP;BMP10;BMP2;CLCF1;CCL2;IL11;IL24;IL6;INHBC;GDF7;CXCR2;EDA;IL1R2;EDA2R;LIF;AMH;IL12RB2;CXCL8;IL23A;IL1A;TNF;EDAR;TNFSF4;IL26;IL2;IL1B;IL2RA;TNFRSF10D;CD70;TNFSF18;TGFB1;TNFSF13;IL12RB1;CCR3;TNFRSF10B;CNTFR;IL3RA;CXCL2;IL18RAP;CD40LG;TNFRSF11B;IL12B;CXCL10;IL20RA
prerank,Inflammatory mediator regulation of TRP channels,0.3767670578964788,1.091415334966294,0.36363636363636365,1.0,1.0,21/84,16.49%,CYP4A11;JMJD7-PLA2G4B;KNG1;HTR2A;NTRK1;CYP2J2;BDKRB1;NGF;ADCY6;HTR2B;ADCY5;HRH1;ADCY4;CALML6;ADCY7;TRPV4;MAPK11;PLCB3;TRPV1;ADCY1;ADCY3
prerank,Graft-versus-host disease,-0.47174354443262534,-1.0862864215382844,0.41935483870967744,1.0,1.0,16/36,25.48%,KIR2DL1;IL6;IL1A;TNF;IL2;IL1B;CD28;HLA-DQA1;HLA-DQB1;HLA-DQA2;HLA-DOB;HLA-DRA;HLA-DRB5;IFNG;HLA-A;HLA-DPB1
prerank,Prolactin signaling pathway,-0.4367955674566616,-1.0855576562088503,0.3333333333333333,1.0,1.0,2/64,1.35%,LHCGR;CGA
prerank,Cocaine addiction,0.3958713380813435,1.0844528647383134,0.3333333333333333,1.0,1.0,10/43,11.61%,DDC;GRIA2;GRIN2B;GRIN3B;GRIN2D;PPP1R1B;SLC18A1;ADCY5;GRIN2A;GRIN3A
prerank,Gap junction,-0.4100458218485815,-1.0821825156676803,0.3625,1.0,1.0,6/74,7.35%,TUBA3D;DRD1;TUBB8;TUBB2A;TUBA1B;PRKCG
prerank,Autoimmune thyroid disease,-0.46860010423478476,-1.0801921718446286,0.373134328358209,1.0,1.0,17/35,28.60%,CGA;IL2;CD28;HLA-DQA1;TPO;HLA-DQB1;CD40LG;HLA-DQA2;HLA-DOB;HLA-DRA;HLA-DRB5;CD40;HLA-A;HLA-DPB1;TG;HLA-DMA;HLA-DMB
prerank,Legionellosis,-0.4499269475701661,-1.078547812584662,0.3611111111111111,1.0,1.0,16/53,16.26%,RAB1B;IL6;CR1;HSPA1A;CXCL8;HSPA6;TNF;IL1B;HSPA1B;NFKBIA;CYCS;CXCL2;HSPA8;IL12B;NFKB2;HSPA2
prerank,Long-term potentiation,0.37828082575829247,1.0694921279267704,0.3333333333333333,1.0,1.0,9/58,15.46%,GRIA2;GRIN2B;GRIA1;GRIN2D;GRIN2A;CALML6;CACNA1C;PLCB3;ADCY1
prerank,Amphetamine addiction,0.37989090650003793,1.0690371235640483,0.3783783783783784,1.0,1.0,19/58,16.45%,DDC;GRIA2;GRIN2B;GRIA1;GRIN3B;GRIN2D;PPP1R1B;SLC18A1;FOS;ADCY5;GRIN2A;GRIN3A;GRIA3;CALML6;CACNA1C;CREB3L1;JUN;ATF6B;CACNA1D
prerank,Bile secretion,0.3906950068045976,1.066009049912272,0.25925925925925924,1.0,1.0,21/52,18.13%,CFTR;SLC5A1;SLC4A2;ATP1A2;AQP9;ABCB1;ADCY6;AQP4;ABCG2;SLC51A;ADCY5;SCT;BAAT;ADCY4;ADCY7;ATP1A3;ADCY1;AQP1;ADCY3;ATP1A4;ABCG5
prerank,Epstein-Barr virus infection,-0.3768243978332201,-1.065301963967726,0.3409090909090909,1.0,1.0,94/179,38.23%,GADD45A;ENTPD8;IL6;CDKN1A;GADD45B;TNF;FCER2;RELB;ISG15;HLA-DQA1;NFKBIB;CD3G;MYC;NFKBIA;CYCS;CD3D;HLA-DQB1;CCND1;MAP2K3;HLA-DQA2;DDB2;CD19;NFKB2;CXCL10;PSMD8;BAK1;HLA-DOB;CCNE2;NFKBIE;HLA-DRA;MAP3K14;TAP1;RUNX3;BID;CALR;HLA-DRB5;PSMD13;CHUK;ICAM1;BAX;AKT3;STAT3;BCL2;OAS2;E2F2;CD40;HLA-A;HLA-DPB1;IRF9;AKT1;OAS1;ADRM1;CASP3;RIPK1;HLA-DMA;B2M;TNFAIP3;PSMC3;PSMD4;HLA-DMB;SKP2;CCND2;PSMD3;PSMC4;HLA-B;CDK2;APAF1;SNW1;CR2;CCND3;HLA-DOA;CCNA2;BCL2L11;JAK3;PSMD11;BLNK;EIF2AK2;IRF3;SIN3A;MAPK8;HLA-E;VIM;IKBKE;CDK6;CCNE1;RELA;PSMC6;TBK1;PSMD7;TAB2;MAPK10;MDM2;LYN;SEM1
prerank,Citrate cycle (TCA cycle),-0.44122685104268616,-1.0540436454496693,0.3870967741935484,1.0,1.0,24/29,48.85%,MDH2;SUCLG1;IDH3A;IDH3G;PCK1;SDHB;OGDHL;SUCLG2;SUCLA2;PDHB;CS;ACO1;SDHC;PCK2;DLST;DLD;SDHD;IDH3B;OGDH;FH;ACLY;PDHA1;DLAT;ACO2
prerank,Cardiac muscle contraction,-0.40386269124878654,-1.0517301280786855,0.3492063492063492,1.0,1.0,24/63,23.41%,CACNA1S;COX6B2;CACNB2;MYL4;FXYD2;COX4I1;CACNA2D3;RYR2;ATP1B1;COX7A2L;COX8A;ATP1B2;COX4I2;SLC9A1;COX5A;COX6A1;UQCRFS1;TNNC1;COX5B;CYC1;UQCRH;CACNG5;TPM4;MYL2
prerank,cGMP-PKG signaling pathway,0.3229450994281526,1.0499580326010212,0.3888888888888889,1.0,1.0,44/148,19.03%,SLC8A2;NPPB;ADRA1D;KNG1;ATP1A2;PRKG2;MYLK3;MYLK2;NPPA;ADRA1A;ADCY6;NPPC;ADRA2C;KCNMB1;ADCY5;PDE3B;ADCY4;EDNRA;ADRB2;AGTR1;GUCY1B1;KCNMB4;PDE3A;CALML6;ADCY7;OPRD1;PDE5A;ATP1A3;CACNA1C;PLCB3;MYLK4;CREB3L1;PIK3R6;ADRA2A;ADCY1;PLN;ATF6B;CACNA1D;ADCY3;ATP1A4;GUCY1A2;PIK3R5;ATP2B4;GUCY1A1
prerank,Vibrio cholerae infection,0.37672878063884163,1.0492935065385087,0.38235294117647056,1.0,1.0,2/45,2.97%,CFTR;ATP6V0D2
prerank,Sphingolipid metabolism,0.39681032092576674,1.0473728845258354,0.45454545454545453,1.0,1.0,4/45,7.17%,ENPP7;ASAH2;ACER1;B4GALT6
prerank,Cholinergic synapse,0.3351217101278328,1.0465684363784733,0.34375,1.0,1.0,26/96,16.49%,SLC18A3;KCNQ3;GNG10;KCNQ2;CACNA1B;KCNJ6;KCNQ4;GNG8;ADCY6;KCNJ2;KCNJ4;FOS;ADCY5;CACNA1A;ADCY4;KCNJ12;ADCY7;CACNA1C;PLCB3;CHRM3;KCNQ5;CREB3L1;PIK3R6;ADCY1;CACNA1D;ADCY3
prerank,Th1 and Th2 cell differentiation,-0.4026570519576311,-1.0434540337067615,0.3670886075949367,1.0,1.0,25/85,23.09%,IL13;IL12RB2;DLL3;MAML3;IL2;IL2RA;NFATC1;HLA-DQA1;NFKBIB;CD3G;IL12RB1;NFKBIA;CD3D;HLA-DQB1;HLA-DQA2;IL12B;HLA-DOB;NFKBIE;HLA-DRA;RUNX3;PPP3R1;HLA-DRB5;DLL4;IFNG;CHUK
prerank,Glycosaminoglycan biosynthesis,0.38634392351644176,1.039542407537867,0.3448275862068966,1.0,1.0,23/50,29.47%,CHST6;NDST3;HS6ST2;HS3ST1;CHST7;HS3ST2;CHST13;FUT8;CSGALNACT2;HS3ST3B1;HS6ST1;B3GNT7;ST3GAL1;CHST11;B3GNT2;CHST12;CHST3;CHST1;ST3GAL2;EXTL2;EXTL3;XYLT2;CHSY1
prerank,Sphingolipid signaling pathway,0.32151651801225567,1.0311271780761622,0.4090909090909091,1.0,1.0,5/118,3.71%,MS4A2;S1PR5;ASAH2;KNG1;ACER1
prerank,Prion diseases,0.38812243786807415,1.0184019254696677,0.46875,1.0,1.0,3/33,9.32%,C8B;C9;C6
prerank,alpha-Linolenic acid metabolism,0.4630109344270068,1.0112511599881095,0.4418604651162791,1.0,1.0,3/18,6.97%,JMJD7-PLA2G4B;PLA2G3;PLA2G10
prerank,Cell adhesion molecules (CAMs),0.29719208747897435,1.0094309912057389,0.5,1.0,1.0,26/135,15.53%,VTCN1;CLDN10;NLGN1;CLDN18;CLDN16;NTNG1;NRXN1;VCAN;CNTN1;CDH4;CNTNAP1;CDH3;CDH5;L1CAM;MPZ;ICAM2;ITGB2;SDC1;CLDN11;CD80;ITGA6;NRXN2;CTLA4;LRRC4C;JAM2;CLDN5
prerank,Ovarian steroidogenesis,-0.4246414291305488,-1.0066029696011538,0.4225352112676056,1.0,1.0,6/36,10.13%,LHCGR;CGA;CYP19A1;LDLR;CYP11A1;HSD17B1
prerank,Folate biosynthesis,-0.47440458462319435,-1.005927934638876,0.46296296296296297,1.0,1.0,6/22,20.22%,AKR1B10;ALPL;AKR1C3;TPH1;TH;PCBD1
prerank,Hypertrophic cardiomyopathy (HCM),-0.3772227464583348,-0.9920968572822798,0.45454545454545453,1.0,1.0,13/76,13.64%,CACNA1S;ITGB7;SGCG;IL6;MYBPC3;LMNA;CACNB2;TNF;ACTG1;TGFB1;CACNA2D3;ITGA2B;RYR2
prerank,Olfactory transduction,-0.41180321176062246,-0.9900825716041738,0.4657534246575342,1.0,1.0,7/46,10.03%,OR2G6;OR2A12;OR2C3;ANO2;SLC24A4;OR56B1;GUCY2D
prerank,Fc epsilon RI signaling pathway,0.351210149895619,0.9840720483537351,0.4827586206896552,1.0,1.0,2/59,1.48%,MS4A2;JMJD7-PLA2G4B
prerank,Influenza A,-0.34707302550737407,-0.9807438380516867,0.5121951219512195,1.0,1.0,51/147,27.55%,PABPN1L;CCL2;IL6;DNAJB1;HSPA1A;CXCL8;HSPA6;IL1A;TNF;IL1B;TICAM1;ACTG1;HLA-DQA1;HSPA1B;NFKBIB;NFKBIA;CYCS;TLR7;TNFRSF10B;NXT2;SOCS3;HLA-DQB1;HSPA8;MAP2K3;PRSS3;HLA-DQA2;IL12B;CXCL10;HSPA2;SLC25A6;HLA-DOB;PYCARD;ACTB;DDX39B;HLA-DRA;VDAC1;HLA-DRB5;EIF2S1;RSAD2;IFNG;ICAM1;AKT3;PRKCB;OAS2;HLA-DPB1;IRF9;AKT1;OAS1;EIF2AK1;MX1;HLA-DMA
prerank,Phospholipase D signaling pathway,0.3062161984084889,0.9805612164999582,0.5833333333333334,1.0,1.0,35/134,22.54%,MS4A2;DGKB;JMJD7-PLA2G4B;GRM7;LPAR4;GRM4;GRM6;AGT;ADCY6;SHC4;DNM1;ADCY5;ADCY4;AGTR1;ADCY7;DNM3;PLCB3;DGKE;PIK3R6;ADCY1;PLPP3;ADCY3;AGPAT5;PIK3R5;PDGFRA;DGKH;PLD1;LPAR6;PIP5K1B;F2R;FYN;FCER1G;KITLG;GAB2;AGPAT1
prerank,Cytosolic DNA-sensing pathway,-0.41034419882214734,-0.9783125786927249,0.4411764705882353,1.0,1.0,18/44,28.66%,IL6;POLR3H;IL1B;NFKBIB;POLR3K;NFKBIA;CXCL10;POLR2F;AIM2;POLR2E;PYCARD;POLR3D;CHUK;CCL4;CCL4L2;RIPK1;POLR3GL;POLR2K
prerank,GABAergic synapse,0.3374941178517658,0.9780019754262701,0.52,1.0,1.0,19/68,16.49%,GABRB2;SLC6A1;GNG10;CACNA1B;KCNJ6;GABRG1;GNG8;ADCY6;GABRA5;ADCY5;CACNA1A;GABRG3;ADCY4;ADCY7;CACNA1C;SLC38A5;ADCY1;CACNA1D;ADCY3
prerank,ECM-receptor interaction,0.33895058163247843,0.9779759285956151,0.5116279069767442,1.0,1.0,18/75,16.31%,SPP1;FN1;COL1A1;COL6A5;ITGA2;LAMB3;COL1A2;COL4A6;COL6A3;RELN;GP6;SV2B;SDC1;TNR;COL6A6;ITGA6;VWF;ITGA8
prerank,PPAR signaling pathway,0.3403894979001012,0.9757092288307226,0.5357142857142857,1.0,1.0,8/63,6.63%,SLC27A6;CYP4A11;FABP7;ILK;RXRG;ACSBG2;LPL;MMP1
prerank,Glycosaminoglycan degradation,0.4434677806684116,0.9728600031938899,0.5384615384615384,1.0,1.0,8/16,27.63%,HYAL1;IDUA;HYAL2;HGSNAT;HPSE;GLB1;ARSB;HEXB
prerank,Measles,-0.36193328234216465,-0.9672725795908416,0.5641025641025641,1.0,1.0,44/119,27.42%,IL6;CLEC4M;HSPA1A;HSPA6;IL1A;IL2;IL1B;IL2RA;CD28;BAD;HSPA1B;NFKBIB;CD3G;NFKBIA;CYCS;CD3D;TLR7;HSPA8;CSNK2B;CCND1;IL12B;RACK1;HSPA2;BBC3;BAK1;CCNE2;EIF3H;BID;CD209;EIF2S1;CHUK;BAX;AKT3;STAT3;BCL2;OAS2;CSNK2A1;IRF9;SLAMF1;AKT1;OAS1;CASP3;EIF2AK1;MX1
prerank,Relaxin signaling pathway,0.2996212835395894,0.9615538559974349,0.5555555555555556,1.0,1.0,25/118,16.49%,NOS1;COL1A1;COL3A1;GNG10;MMP1;GNG8;COL1A2;COL4A6;ADCY6;SHC4;FOS;ADCY5;ACTA2;EDN1;ADCY4;ADCY7;MAPK11;PLCB3;MMP2;CREB3L1;JUN;ADCY1;NOS2;ATF6B;ADCY3
prerank,Vitamin B6 metabolism,-0.581489398972554,-0.9583581996859519,0.5384615384615384,1.0,1.0,3/5,24.51%,PHOSPHO2;PNPO;AOX1
prerank,Long-term depression,0.352862452783096,0.9557356952670126,0.5357142857142857,1.0,1.0,9/53,13.79%,JMJD7-PLA2G4B;GRIA2;NOS1;PRKG2;GRIA1;CACNA1A;GRIA3;GUCY1B1;PLCB3
prerank,Retinol metabolism,0.3967754938272706,0.9463334020503174,0.46511627906976744,1.0,1.0,10/32,16.95%,CYP4A11;DHRS4L1;UGT2A1;RDH12;CYP2S1;BCO1;CYP2C8;ALDH1A2;CYP3A5;HSD17B6
prerank,Bacterial invasion of epithelial cells,0.3273577254717653,0.942851014081414,0.55,1.0,1.0,6/64,9.75%,FN1;CAV3;ILK;SHC4;DNM1;MET
prerank,Axon guidance,0.2645037879694853,0.9385429474582623,0.6666666666666666,1.0,1.0,47/171,25.76%,UNC5D;ILK;DCC;EPHA8;SLIT1;NTNG1;UNC5A;NGEF;TRPC4;SEMA3C;EPHA5;SEMA3G;MET;EFNA2;TRPC3;WNT5A;PLXNC1;NTN4;L1CAM;CXCL12;ABLIM2;LRRC4C;WNT5B;PLXNA3;NRP1;UNC5B;SSH1;RASA1;EFNB3;PDK1;EPHA3;SEMA6C;BMPR1B;FYN;PPP3CB;SEMA6D;SEMA5A;ENAH;SLIT3;EFNB1;ROCK2;SEMA4B;PAK4;BMPR2;SEMA3B;MAPK1;NFATC4
prerank,Linoleic acid metabolism,0.417129910304855,0.9371461127907835,0.6041666666666666,1.0,1.0,6/19,13.09%,JMJD7-PLA2G4B;PLA2G3;CYP2J2;PLA2G10;CYP2E1;CYP2C8
prerank,Huntington disease,-0.32898365880495084,-0.9327767803395225,0.6626506024096386,1.0,1.0,96/179,36.05%,DNAH2;BDNF;DNAH9;COX6B2;DNAH11;HAP1;DNAI1;DNAH6;NDUFA7;DNAH10;COX4I1;SLC25A4;NDUFC2;NDUFA4L2;CYCS;DNAH8;ATP5MC2;ATP5MC1;DNALI1;NDUFS8;PPARGC1A;NDUFA12;COX7A2L;COX8A;NDUFB11;NDUFB7;NDUFB9;POLR2F;SLC25A6;BBC3;ATP5PO;AP2S1;COX4I2;POLR2E;POLR2C;CREB3;COX5A;SLC25A5;COX6A1;VDAC3;UQCRFS1;AP2M1;VDAC2;NDUFB10;NDUFAB1;POLR2J2;COX5B;DNAH12;NDUFB5;VDAC1;DNAL4;CYC1;UQCRH;POLR2J;POLR2I;DNAH7;BAX;NDUFB8;GPX1;SOD1;ATP5PD;ATP5MC3;CLTA;ATP5F1C;PLCB4;CASP3;NDUFS6;DCTN1;NDUFA10;SDHB;NDUFS4;POLR2K;UQCRB;ATP5F1A;NDUFV2;UQCRC1;ITPR1;APAF1;NDUFA2;NDUFS7;CLTCL1;NDUFA11;NDUFA4;GRIN1;NDUFA6;SIN3A;DNAL1;POLR2H;NDUFA5;NDUFS3;PPIF;SDHC;UQCRC2;ATP5PF;NDUFB2;HTT
prerank,Pyruvate metabolism,-0.38496089124314536,-0.9304667328706795,0.5797101449275363,1.0,1.0,23/33,48.55%,ACAT2;LDHD;MDH2;ALDH1B1;LDHA;ACACA;PCK1;LDHB;PDHB;PCK2;DLD;GRHPR;ALDH2;ME1;ACYP2;FH;HAGH;ALDH3A2;ALDH7A1;GLO1;PKM;PDHA1;DLAT
prerank,Nicotinate and nicotinamide metabolism,0.34585330028858124,0.9285043840145343,0.6153846153846154,1.0,1.0,4/29,8.75%,ASPDH;NT5C1A;NMRK2;NAPRT
prerank,Phenylalanine metabolism,0.4307564963370773,0.9256073646437429,0.58,1.0,1.0,1/13,0.01%,DDC
prerank,Pentose and glucuronate interconversions,-0.4724719551742982,-0.9253879139830459,0.5789473684210527,1.0,1.0,3/15,7.70%,AKR1B10;KL;XYLB
prerank,Homologous recombination,0.3372030149385283,0.9246130988982061,0.6382978723404256,1.0,1.0,12/39,24.13%,XRCC2;EME1;SYCP3;POLD1;RAD54L;PALB2;RAD54B;XRCC3;POLD4;TOP3A;RAD51D;RAD51
prerank,Thyroid hormone synthesis,0.3272750742564716,0.9203891652339539,0.6,1.0,1.0,16/66,16.49%,TTR;GPX2;ATP1A2;ADCY6;ADCY5;ASGR2;ADCY4;ADCY7;ALB;ATP1A3;PLCB3;CREB3L1;ADCY1;SLC5A5;ATF6B;ADCY3
prerank,Tryptophan metabolism,0.3623756183890141,0.9158725448859318,0.6451612903225806,1.0,1.0,2/39,5.25%,DDC;CYP1B1
prerank,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,-0.42188682190913673,-0.9151295216767577,0.6349206349206349,1.0,1.0,8/24,20.57%,PIGF;DPM2;PGAP1;GPLD1;GPAA1;PIGS;PIGB;PIGA
prerank,Retrograde endocannabinoid signaling,0.3016183901508265,0.9140349068210556,0.5454545454545454,1.0,1.0,25/115,16.49%,GABRB2;GRIA2;GNG10;CACNA1B;KCNJ6;GABRG1;GRIA1;GNG8;ADCY6;GABRA5;ADCY5;CACNA1A;GABRG3;ADCY4;SLC17A7;GRIA3;ADCY7;NDUFB1;CACNA1C;MAPK11;PLCB3;KCNJ5;ADCY1;CACNA1D;ADCY3
prerank,IL-17 signaling pathway,-0.3591821106861418,-0.9130652319574364,0.6119402985074627,1.0,1.0,11/77,10.06%,IL13;FOSL1;CSF3;FOSB;CCL2;IL6;CXCL8;JUND;TNF;IL1B;MAPK6
prerank,Dilated cardiomyopathy (DCM),-0.35263586695776805,-0.9086155899195741,0.640625,1.0,1.0,12/79,13.64%,CACNA1S;ITGB7;SGCG;MYBPC3;LMNA;CACNB2;TNF;ACTG1;TGFB1;CACNA2D3;ITGA2B;RYR2
prerank,Endometrial cancer,-0.3704872575692766,-0.8988102081682695,0.625,1.0,1.0,10/55,16.82%,GADD45A;CTNNA3;CDKN1A;GADD45B;BAD;MYC;CCND1;DDB2;ELK1;BAK1
prerank,Collecting duct acid secretion,-0.43736652933034664,-0.8966503267121902,0.660377358490566,1.0,1.0,4/22,10.15%,ATP4A;ATP4B;ATP6V1C2;ATP6V0E2
prerank,Basal transcription factors,-0.38873312454051984,-0.8937187249841764,0.5588235294117647,1.0,1.0,2/41,4.41%,GTF2A1L;TAF7L
prerank,Insulin secretion,0.31270497068622344,0.8926041016815183,0.7692307692307693,1.0,1.0,20/72,16.49%,ADCYAP1;RIMS2;SNAP25;ATP1A2;ADCY6;KCNMB1;ADCY5;ADCY4;KCNMB4;ADCY7;ATP1A3;CACNA1C;PLCB3;CHRM3;CREB3L1;ADCY1;PCLO;ATF6B;CACNA1D;ADCY3
prerank,African trypanosomiasis,-0.3915858067633571,-0.892138721250036,0.6142857142857143,1.0,1.0,14/34,23.62%,IL6;HBA2;HBB;HBA1;PRKCG;TNF;IL1B;IL12B;IDO1;IDO2;F2RL1;IFNG;ICAM1;PRKCB
prerank,Viral myocarditis,-0.37249214900753413,-0.8916103720654656,0.65625,1.0,1.0,25/56,28.60%,SGCG;CD28;ACTG1;HLA-DQA1;CYCS;CAV1;HLA-DQB1;CCND1;CD40LG;HLA-DQA2;HLA-DOB;SGCD;ACTB;HLA-DRA;BID;HLA-DRB5;CXADR;ICAM1;CD40;HLA-A;HLA-DPB1;CASP3;HLA-DMA;EIF4G2;HLA-DMB
prerank,Type I diabetes mellitus,-0.3790476576756216,-0.8811843733515939,0.7230769230769231,1.0,1.0,21/38,28.70%,IL1A;TNF;IL2;IL1B;CD28;HLA-DQA1;HLA-DQB1;HLA-DQA2;IL12B;HLA-DOB;HLA-DRA;HLA-DRB5;IFNG;HSPD1;HLA-A;LTA;HLA-DPB1;PTPRN2;HLA-DMA;HLA-DMB;ICA1
prerank,C-type lectin receptor signaling pathway,-0.3437801356268643,-0.8790466624879973,0.7432432432432432,1.0,1.0,27/96,23.49%,EGR3;IL6;CLEC4M;EGR2;IL23A;TNF;IL2;RELB;IL1B;BCL10;NFATC1;NFKBIA;CLEC4E;BCL3;IL12B;IRF1;NFKB2;PLK3;RRAS;PYCARD;MAP3K14;CLEC4D;PPP3R1;CD209;CHUK;LSP1;AKT3
prerank,Thiamine metabolism,-0.47215965293528417,-0.8770410227386345,0.6792452830188679,1.0,1.0,6/11,28.25%,ALPL;ACP1;AK2;AK5;TPK1;AK7
prerank,Cysteine and methionine metabolism,-0.36887938324297614,-0.8731264811918118,0.6721311475409836,1.0,1.0,18/41,28.73%,KYAT1;MAT1A;GCLC;MAT2A;MDH2;CBS;AMD1;AHCY;LDHA;SDSL;BCAT2;GOT1;SMS;SDS;LDHB;MPST;CTH;AHCYL1
prerank,Calcium signaling pathway,0.2689037435942647,0.8713187240058821,0.8,1.0,1.0,45/159,16.49%,SLC8A2;P2RX6;NOS1;ADRA1D;PTGER1;HTR2A;PTGER3;CACNA1G;CACNA1B;CAMK1G;BDKRB1;MYLK3;MYLK2;ADRA1A;GRIN2D;HRH2;P2RX1;HTR2B;ADORA2B;PLCD3;TBXA2R;CACNA1A;GRIN2A;PDE1C;HRH1;ADCY4;EDNRA;ADRB2;AGTR1;CACNA1I;CALML6;ADCY7;CACNA1C;PLCB3;CHRM3;MYLK4;TPCN2;ADCY1;NTSR1;NOS2;CACNA1H;PLN;P2RX5;CACNA1D;ADCY3
prerank,NOD-like receptor signaling pathway,-0.32003516278288857,-0.8655861614090847,0.8117647058823529,1.0,1.0,46/146,28.52%,PYDC1;RNF31;GBP7;CAMP;CCL2;IL6;GBP1;P2RX7;CXCL8;TNF;GABARAP;IL1B;CASP12;TICAM1;NFKBIB;NFKBIA;GABARAPL1;TP53BP1;CXCL2;MFN2;AIM2;GBP2;PYCARD;GABARAPL2;GBP5;TXN2;VDAC3;CYBA;NOD1;VDAC2;TRIP6;VDAC1;CHUK;ATG5;BCL2;OAS2;IRF9;HSP90AA1;SHARPIN;OAS1;PLCB4;RIPK1;SUGT1;RIPK2;TNFAIP3;HSP90AB1
prerank,GnRH signaling pathway,-0.3487650301767283,-0.864564604357005,0.7647058823529411,1.0,1.0,2/82,1.35%,CACNA1S;CGA
prerank,beta-Alanine metabolism,0.33731892543183556,0.862732424694721,0.675,1.0,1.0,5/26,14.01%,CNDP1;ALDH3B1;ALDH3A1;ALDH1A3;AOC3
prerank,Adipocytokine signaling pathway,-0.33985466287376187,-0.8602533077616027,0.7083333333333334,1.0,1.0,10/63,14.85%,NPY;ACSBG1;POMC;TNF;SLC2A4;NFKBIB;NFKBIA;IRS2;SOCS3;PPARGC1A
prerank,cAMP signaling pathway,-0.3050145140474632,-0.8593189630691304,0.7195121951219512,1.0,1.0,22/176,12.01%,CACNA1S;NPY;DRD1;CGA;HCAR2;ADCY10;BDNF;EDN2;HCN4;VIP;AMH;POMC;OXTR;PDE10A;SSTR2;GLP1R;HTR1E;FXYD2;NFATC1;BAD;CNGA1;GLI1
prerank,Drug metabolism,-0.3286758920095804,-0.8568674811419109,0.6811594202898551,1.0,1.0,23/69,26.72%,CES1;CYP1A2;GSTT2B;GSTM3;NME4;GSTO2;FMO3;GSTP1;GSTM4;MAOA;RRM2B;TK1;IMPDH2;RRM2;UPB1;NME1;TPMT;AOX1;UMPS;ITPA;CDA;GSTK1;UPP1
prerank,Shigellosis,-0.34068834243049767,-0.8494045273240344,0.7432432432432432,1.0,1.0,34/62,38.35%,CXCL8;ACTG1;NFKBIB;NFKBIA;PFN1;MAD2L2;U2AF1L4;WASF2;RHOG;ITGA5;ACTB;NOD1;CHUK;ARPC5L;VCL;ATG5;UBE2D2;RIPK2;PFN2;DIAPH1;WASL;ARPC3;CRK;HCLS1;ARPC5;MAPK8;CTTN;ARPC2;ABL1;RELA;ARPC4;MAPK10;ITGB1;NOD2
prerank,Tight junction,-0.30003604241023696,-0.8487221097181511,0.8133333333333334,1.0,1.0,34/149,20.71%,TUBA3D;MYH1;CLDN2;CLDN6;CLDN9;TJP2;PRKCZ;LLGL1;TUBA1B;PARD6B;CLDN4;CLDN3;AMOTL2;PARD6A;RAB8A;CRB3;ACTG1;TUBA1C;MYH14;EZR;CCND1;CLDN7;MYL6;JAM3;CD1C;EPB41L4B;PARD3;MYL12A;ACTB;ARHGAP17;STK11;MYH15;PPP2CA;MYL12B
prerank,Glycerolipid metabolism,0.3084906225568085,0.8457702232250209,0.7096774193548387,1.0,1.0,4/51,6.44%,PNPLA3;DGKB;CEL;LPL
prerank,Hedgehog signaling pathway,-0.353713461105937,-0.8447915643057897,0.7222222222222222,1.0,1.0,5/44,14.38%,IHH;CSNK1A1L;GPR161;GLI1;CCND1
prerank,Allograft rejection,-0.373082267884148,-0.8407194731017096,0.6935483870967742,1.0,1.0,19/34,31.82%,TNF;IL2;CD28;HLA-DQA1;HLA-DQB1;CD40LG;HLA-DQA2;IL12B;HLA-DOB;HLA-DRA;HLA-DRB5;IFNG;CD40;HLA-A;HLA-DPB1;HLA-DMA;HLA-DMB;HLA-B;HLA-DOA
prerank,Purine metabolism,-0.31210422102960467,-0.8397893882692486,0.7183098591549296,1.0,1.0,22/118,18.63%,ALLC;PDE6H;NT5C1B;ADCY10;ENTPD8;GMPR;PDE10A;GUCY2D;NME4;PDE8B;NT5C3B;PDE6G;PDE6B;GUK1;APRT;ENTPD5;NT5C2;RRM2B;PDE1B;ENTPD6;IMPDH2;RRM2
prerank,Non-alcoholic fatty liver disease (NAFLD),-0.30277692745708623,-0.8391055361616222,0.7228915662650602,1.0,1.0,59/138,34.65%,IL6;COX6B2;CXCL8;IL1A;TNF;IL1B;NDUFA7;COX4I1;TGFB1;NDUFC2;NDUFA4L2;CYCS;IRS2;SOCS3;NDUFS8;NDUFA12;COX7A2L;COX8A;NDUFB11;NDUFB7;NDUFB9;COX4I2;COX5A;COX6A1;UQCRFS1;MLX;NDUFB10;BID;NDUFAB1;COX5B;NDUFB5;CYC1;UQCRH;EIF2S1;BAX;AKT3;NDUFB8;AKT1;CASP3;NDUFS6;NDUFA10;SDHB;NDUFS4;UQCRB;GSK3A;NDUFV2;MLXIP;UQCRC1;NDUFA2;ITCH;NDUFS7;NDUFA11;BCL2L11;NDUFA4;INSR;NDUFA6;MAPK8;NDUFA5;NDUFS3
prerank,Melanogenesis,0.2854669351854029,0.837669128358876,0.7666666666666667,1.0,1.0,27/87,22.61%,ADCY6;FZD8;WNT9A;WNT3;ADCY5;WNT1;EDN1;WNT5A;ADCY4;WNT6;WNT10B;WNT16;CALML6;ADCY7;PLCB3;CREB3L1;WNT2;ADCY1;WNT5B;ADCY3;FZD7;FZD9;CREB3L2;FZD4;FZD2;KITLG;WNT10A
prerank,Cellular senescence,-0.29500527447496105,-0.8348580450752271,0.8157894736842105,1.0,1.0,40/150,26.49%,KIR2DL1;SERPINE1;GADD45A;IL6;CDKN1A;PPID;GADD45B;MYBL2;CCNB2;CXCL8;IL1A;NFATC1;SLC25A4;TGFB1;MYC;RBL2;CCND1;MAP2K3;SLC25A6;RAD9A;RRAS;CCNE2;SLC25A5;VDAC3;VDAC2;PPP3R1;VDAC1;LIN52;HIPK1;FOXO3;AKT3;E2F2;HLA-A;CDC25A;SQSTM1;CAPN1;CDK1;AKT1;KRAS;RAD9B
prerank,Human T-cell leukemia virus 1 infection,-0.2917623713499895,-0.8309763618448555,0.7954545454545454,1.0,1.0,63/208,26.87%,FOSL1;SRF;IL6;CDKN1A;EGR2;IL1R2;CCNB2;TNF;IL2;RELB;IL2RA;MAD1L1;NFATC1;SLC25A4;TGFB1;HLA-DQA1;CD3G;MYC;TERT;NFKBIA;CD3D;HLA-DQB1;CCND1;HLA-DQA2;CDC20;MAD2L1;NFKB2;ELK1;ANAPC11;SLC25A6;RAN;HLA-DOB;CCNE2;CREB3;SLC25A5;HLA-DRA;VDAC3;MAP3K14;ADCY2;VDAC2;PPP3R1;CALR;ETS2;VDAC1;HLA-DRB5;CHUK;ICAM1;BAX;AKT3;ZFP36;TSPO;E2F2;CD40;ELK4;HLA-A;LTA;HLA-DPB1;TLN1;ANAPC5;AKT1;KRAS;CDKN2C;ANAPC2
prerank,Fatty acid biosynthesis,-0.41402755076943076,-0.8304719767059371,0.6774193548387096,1.0,1.0,1/13,2.77%,ACSBG1
prerank,Phosphonate and phosphinate metabolism,0.45235769903432343,0.8299881831629723,0.6153846153846154,1.0,1.0,3/5,32.51%,CEPT1;CHPT1;PCYT1A
prerank,Asthma,0.3612193111250172,0.8272413668726937,0.7317073170731707,1.0,1.0,2/22,2.61%,MS4A2;CCL11
prerank,Maturity onset diabetes of the young,-0.4317865922468848,-0.8223442888803807,0.6031746031746031,1.0,1.0,2/10,3.06%,BHLHA15;MAFA
prerank,Colorectal cancer,-0.3151973779381611,-0.8202412365595447,0.7702702702702703,1.0,1.0,13/83,16.82%,AREG;GADD45A;CDKN1A;GADD45B;BIRC5;TGFB1;BAD;MYC;CYCS;CCND1;DDB2;BBC3;BAK1
prerank,Central carbon metabolism in cancer,0.28940463932164956,0.8197590559319281,0.8,1.0,1.0,6/58,10.62%,NTRK1;RET;HK3;FGFR3;MET;SLC16A3
prerank,NF-kappa B signaling pathway,-0.32233026610967236,-0.8167824588085014,0.863013698630137,1.0,1.0,36/88,31.52%,GADD45B;CXCL8;TNF;RELB;IL1B;BCL10;TICAM1;NFKBIA;CXCL2;CSNK2B;CD40LG;NFKB2;CCL21;CCL19;LTB;MAP3K14;CARD14;CHUK;ICAM1;BCL2A1;PRKCB;UBE2I;BCL2;CD40;CSNK2A1;LTA;ERC1;CCL4;CCL4L2;RIPK1;TNFAIP3;CARD11;TRAF1;LCK;TNFSF13B;TAB3
prerank,Chemokine signaling pathway,0.23617101515881883,0.8148967859827213,0.9565217391304348,1.0,1.0,26/172,16.60%,CCL1;CCL20;CCL11;PF4;CCL26;GNG10;CCR4;GNG8;CXCL14;ADCY6;SHC4;CCR9;ADCY5;XCL1;ADCY4;XCL2;ADCY7;CXCL1;CCL7;PLCB3;CXCL12;PIK3R6;ADCY1;CCL17;ADCY3;CCR2
prerank,Adrenergic signaling in cardiomyocytes,0.264422595281868,0.8141701765834195,0.9230769230769231,1.0,1.0,32/126,18.83%,ADRA1D;MYH6;ATP1A2;AGT;ADRA1A;ADCY6;PPP2R2C;AGTR2;CACNA2D4;ADCY5;ADCY4;ADRB2;AGTR1;CACNA2D2;CALML6;ADCY7;ATP1A3;CACNA1C;MAPK11;PLCB3;CREB3L1;CACNB1;PIK3R6;ADCY1;PLN;ATF6B;CACNA1D;ADCY3;ATP1A4;TPM2;PIK3R5;ATP2B4
prerank,Ubiquitin mediated proteolysis,-0.28398788931941915,-0.8130243924733997,0.7848101265822784,1.0,1.0,44/134,33.28%,AIRE;UBE2S;UBE2C;UBE2QL1;UBE4A;TRIM37;PPIL2;SOCS3;CBLC;CDC20;DDB2;ANAPC11;SKP1;ELOC;UBE2B;FANCL;UBE2F;UBE2N;STUB1;UBE2E1;UBE2I;SAE1;UBE2D2;ANAPC5;TRIM32;ANAPC2;UBE2A;UBA2;NEDD4L;UBE2D3;SKP2;ANAPC10;UBE4B;UBA6;PIAS2;ELOB;KEAP1;ITCH;ANAPC13;UBE2J2;UBE2L6;RNF7;WWP1;FBXO2
prerank,Alzheimer disease,-0.28690181730344433,-0.8113881529087252,0.8513513513513513,1.0,1.0,63/159,31.84%,CACNA1S;COX6B2;TNF;IL1B;CASP12;NDUFA7;COX4I1;BAD;HSD17B10;NDUFC2;NDUFA4L2;CYCS;MAPT;ATP5MC2;PSENEN;ATP5MC1;NDUFS8;NDUFA12;COX7A2L;COX8A;NDUFB11;ATP2A1;NDUFB7;NDUFB9;GAPDH;ATP5PO;COX4I2;COX5A;COX6A1;UQCRFS1;CDK5;NDUFB10;BID;PPP3R1;NDUFAB1;ADAM17;COX5B;NDUFB5;CYC1;UQCRH;NDUFB8;ATP5PD;ATP5MC3;SNCA;CAPN1;ATP5F1C;PLCB4;CASP3;NDUFS6;NDUFA10;SDHB;NDUFS4;APH1A;UQCRB;ATP5F1A;NDUFV2;UQCRC1;ITPR1;RTN3;APAF1;NDUFA2;NDUFS7;NDUFA11
prerank,Carbohydrate digestion and absorption,0.31540329149769564,0.8091998516805224,0.7352941176470589,1.0,1.0,6/30,17.97%,SLC5A1;ATP1A2;HK3;ATP1A3;CACNA1D;ATP1A4
prerank,Non-small cell lung cancer,-0.3142216494977202,-0.805704035676126,0.8225806451612904,1.0,1.0,17/65,26.42%,GADD45A;CDKN1A;PRKCG;GADD45B;BAD;CCND1;DDB2;BAK1;FOXO3;BAX;AKT3;PRKCB;STAT3;E2F2;FHIT;AKT1;KRAS
prerank,Taste transduction,-0.31144898354602724,-0.8056729001659847,0.7681159420289855,1.0,1.0,5/43,7.86%,TAS2R5;HCN4;TAS2R30;TAS2R31;TRPM5
prerank,Glucagon signaling pathway,0.2687437101461433,0.8054804429041825,0.8666666666666667,1.0,1.0,16/83,23.27%,PRKAG3;SIK1;GCGR;PDE3B;PRKAG1;CPT1A;CALML6;PLCB3;CREB3L1;PRKAB2;PYGL;PHKG1;CREB3L2;PPP3CB;PFKFB1;ACACB
prerank,"Neomycin, kanamycin and gentamicin biosynthesis",0.41255429315077957,0.8049479839598337,0.7111111111111111,1.0,1.0,1/5,5.99%,HK3
prerank,Hepatitis B,-0.2925506847931812,-0.8024332480737052,0.8125,1.0,1.0,36/144,27.11%,EGR3;IL6;CDKN1A;EGR2;PRKCG;CXCL8;BIRC5;TNF;CASP12;TICAM1;NFATC1;TGFB1;BAD;MYC;NFKBIA;CYCS;MAP2K3;DDB2;ELK1;CCNE2;DDX3X;CREB3;VDAC3;BID;SLC10A1;CHUK;BAX;AKT3;PRKCB;STAT3;BCL2;E2F2;AKT1;KRAS;YWHAQ;CASP3
prerank,RNA degradation,-0.29962602461139626,-0.8005215495584163,0.7903225806451613,1.0,1.0,36/73,40.69%,EDC4;EXOSC5;EXOSC4;PAN2;LSM7;EXOSC7;DCPS;LSM3;LSM1;LSM2;ENO1;BTG3;TOB2;CNOT10;NUDT16;PFKP;PNLDC1;LSM4;HSPD1;TOB1;PABPC5;EXOSC1;EXOSC3;CNOT8;MPHOSPH6;ZCCHC7;LSM6;PARN;DCP1A;LSM8;PATL1;EXOSC8;LSM5;TENT4B;DIS3;PNPT1
prerank,Primary immunodeficiency,-0.3617026203119961,-0.7996947242797168,0.782608695652174,1.0,1.0,10/35,24.49%,AIRE;CD79A;CD3D;CD40LG;CD19;TAP1;ORAI1;RFXANK;TNFRSF13B;CD40
prerank,Selenocompound metabolism,-0.39166853679874425,-0.7991071549836305,0.7288135593220338,1.0,1.0,1/16,3.59%,KYAT1
prerank,RNA polymerase,-0.3664221990008546,-0.7969989742346152,0.8070175438596491,1.0,1.0,12/29,28.66%,POLR3H;POLR3K;POLR2F;POLR2E;POLR2C;POLR3D;POLR2J2;POLR2J;POLR2I;POLR1A;POLR3GL;POLR2K
prerank,Ras signaling pathway,0.2320240793380871,0.7955868969858942,1.0,1.0,1.0,50/202,25.67%,JMJD7-PLA2G4B;GRIN2B;PLA2G3;NTRK1;GNG10;RASA4;FGF10;RAPGEF5;GNG8;NGF;PLA2G10;FGFR3;SHC4;FGF18;MET;EFNA2;ANGPT4;GRIN2A;RASA4B;TGFA;CALML6;RASGRP4;HGF;FGF7;RASGRF1;RASAL2;FASLG;TEK;RASA1;KSR1;PDGFRA;NTF3;PLD1;IKBKB;RGL1;PLCE1;KITLG;GAB2;RASGRP1;RASGRF2;CSF1R;EGFR;ANGPT1;PAK4;BRAP;IGF1;CSF1;SYNGAP1;BCL2L1;MAPK1
prerank,Natural killer cell mediated cytotoxicity,0.2680631646317053,0.7946971183724659,0.9354838709677419,1.0,1.0,8/101,8.98%,KIR2DS4;KIR2DL4;FCGR3B;KIR2DL3;RAET1E;NCR1;SHC4;MICB
prerank,Pancreatic cancer,-0.31362824044520005,-0.7943385054901927,0.8356164383561644,1.0,1.0,17/73,26.42%,GADD45A;CDKN1A;GADD45B;BRCA2;TGFB1;BAD;CCND1;DDB2;BAK1;CHUK;BAX;AKT3;STAT3;E2F2;RPS6KB2;AKT1;KRAS
prerank,MAPK signaling pathway,-0.2681733774728696,-0.7941601467848896,0.9294117647058824,1.0,1.0,51/269,20.34%,CACNA1S;AREG;DUSP9;GADD45A;BDNF;NTF4;SRF;EPHA2;CACNA1E;PRKCG;GADD45B;CACNB2;HSPA1A;DUSP8;EFNA1;HSPA6;JUND;IL1A;TNF;RELB;IL1B;DUSP2;ERBB4;NFATC1;TGFB1;HSPA1B;MYC;CACNA2D3;HSPB1;VEGFD;MAPT;HSPA8;MAP2K3;NFKB2;ELK1;FGF9;FGFR4;HSPA2;FGF17;NTRK2;RRAS;ECSIT;DUSP4;EFNA5;STMN1;KIT;PTPN5;MAP3K14;FLNC;MAP2K5;MAPK8IP2
prerank,Cell cycle,-0.28594358996001534,-0.7911717324588338,0.8356164383561644,1.0,1.0,47/121,34.60%,SMC1B;GADD45A;CDKN1A;GADD45B;CCNB2;ORC1;WEE1;PLK1;MAD1L1;TGFB1;MYC;RBL2;MAD2L2;CCND1;CDC20;MAD2L1;ANAPC11;SKP1;CCNE2;ZBTB17;E2F2;CDC25A;YWHAE;ANAPC5;CDK1;CDKN2C;ANAPC2;YWHAQ;SKP2;CCND2;ANAPC10;CCNB1;YWHAZ;ORC5;CDK2;CCND3;ANAPC13;ORC4;MCM5;CCNA2;CCNH;CDC25C;STAG2;BUB1B;TGFB2;CDKN2A;YWHAB
prerank,Focal adhesion,0.24293078324541642,0.7904868850116145,0.9310344827586207,1.0,1.0,16/190,9.75%,SPP1;FN1;CAV3;ILK;COL1A1;COL6A5;ITGA2;MYLK3;LAMB3;MYLK2;COL1A2;COL4A6;COL6A3;SHC4;RELN;MET
prerank,Progesterone-mediated oocyte maturation,0.244875045895109,0.7897331353540639,0.9655172413793104,1.0,1.0,12/84,16.49%,SPDYA;CCNB3;ADCY6;ADCY5;PDE3B;ADCY4;ADCY7;ANAPC4;MAPK11;CPEB3;ADCY1;ADCY3
prerank,Antigen processing and presentation,0.2761422801808129,0.7890066388990136,0.8846153846153846,1.0,1.0,3/66,4.03%,KIR2DS4;KIR2DL4;KIR2DL3
prerank,Galactose metabolism,-0.3452570199638254,-0.7878957823275634,0.7540983606557377,1.0,1.0,1/25,2.65%,AKR1B10
prerank,Autophagy,-0.2939864369265258,-0.7878364487993642,0.8375,1.0,1.0,47/123,38.42%,ATG101;RUBCN;VMP1;TP53INP2;GABARAP;ATG9A;BAD;RAB7B;GABARAPL1;IRS2;RRAS;GABARAPL2;ATG10;BECN1;STK11;VAMP8;PPP2CA;DEPTOR;EIF2S1;AKT3;ATG5;BCL2;RPS6KB2;AKT1;UVRAG;RRAGA;KRAS;MTMR14;RB1CC1;RRAGB;ITPR1;NRBF2;IGBP1;RAB33B;TSC1;RRAGC;RRAGD;MAPK8;HMGB1;ATG13;MLST8;CTSL;PRKCQ;NRAS;MAPK10;AKT1S1;PPP2CB
prerank,Nitrogen metabolism,0.35502529514804154,0.7831822655775917,0.75,1.0,1.0,6/15,17.55%,CA1;CA5A;CA3;CA5B;GLUD2;CA12
prerank,Ether lipid metabolism,0.2966573905904852,0.7819908379960482,0.868421052631579,1.0,1.0,8/40,16.88%,JMJD7-PLA2G4B;PLA2G3;PLA2G10;LPCAT4;PLPP3;ENPP6;CEPT1;GDPD3
prerank,Chronic myeloid leukemia,-0.2956882467309976,-0.7809405896164272,0.8428571428571429,1.0,1.0,31/74,38.49%,GADD45A;CDKN1A;GADD45B;TGFB1;BAD;MYC;NFKBIA;BCR;CCND1;DDB2;BAK1;CHUK;BAX;AKT3;E2F2;CTBP1;AKT1;KRAS;SHC2;CRK;SHC1;PTPN11;SOS2;TGFB2;CDKN2A;ABL1;CDK6;RELA;NRAS;MDM2;GRB2
prerank,Apoptosis,-0.28321702669716603,-0.778655161592998,0.8961038961038961,1.0,1.0,38/132,27.80%,TUBA3D;GADD45A;TUBA1B;LMNA;GADD45B;BIRC5;TNF;CASP12;ACTG1;BAD;TUBA1C;NFKBIA;CYCS;TNFRSF10B;IL3RA;CTSV;MCL1;BBC3;BAK1;BECN1;ACTB;MAP3K14;BID;EIF2S1;CHUK;BCL2A1;BAX;AKT3;BCL2;TUBA4A;CAPN1;AKT1;KRAS;CASP3;HTRA2;RIPK1;TUBA1A;BOK
prerank,mRNA surveillance pathway,-0.3053908851000742,-0.7778590870688529,0.8714285714285714,1.0,1.0,8/83,13.63%,PABPN1L;MSI1;SMG6;RBM8A;EIF4A3;ETF1;RNGTT;NXT2
prerank,Type II diabetes mellitus,-0.3393096374994619,-0.7716762651660473,0.7936507936507936,1.0,1.0,8/40,13.66%,MAFA;PRKCZ;CACNA1E;TNF;SLC2A4;HK2;IRS2;SOCS3
prerank,Cushing syndrome,0.23681722119735568,0.7712915654993797,0.9583333333333334,1.0,1.0,33/135,16.87%,CACNA1G;AGT;STAR;ADCY6;CRHR2;FZD8;AHR;WNT9A;WNT3;ADCY5;WNT1;CDKN2B;WNT5A;ADCY4;WNT6;AGTR1;WNT10B;WNT16;CACNA1I;ADCY7;CACNA1C;PLCB3;CDK4;CREB3L1;WNT2;KCNK3;ADCY1;WNT5B;CACNA1H;ATF6B;CACNA1D;ADCY3;CDKN1B
prerank,Mismatch repair,0.327352078388504,0.7708727308306391,0.7209302325581395,1.0,1.0,6/22,22.42%,PMS2;POLD1;MLH3;EXO1;POLD4;MSH2
prerank,Chemical carcinogenesis,-0.31418461388053365,-0.7702124501847046,0.8166666666666667,1.0,1.0,9/38,15.21%,KYAT1;CHRNA7;CYP1A2;AKR1C2;GSTT2B;GSTM3;GSTO2;GSTP1;GSTM4
prerank,Aldosterone synthesis and secretion,0.25773635976103276,0.7660457950887396,0.8518518518518519,1.0,1.0,24/84,16.49%,CACNA1G;ATP1A2;CAMK1G;AGT;STAR;NPPA;ADCY6;ADCY5;ADCY4;AGTR1;CACNA1I;CALML6;ADCY7;ATP1A3;CACNA1C;PLCB3;KCNJ5;CREB3L1;KCNK3;ADCY1;CACNA1H;ATF6B;CACNA1D;ADCY3
prerank,Oxytocin signaling pathway,0.2494517627885028,0.7660156748250434,0.9259259259259259,1.0,1.0,33/134,18.33%,JMJD7-PLA2G4B;PRKAG3;KCNJ6;CAMK1G;MYLK3;MYLK2;NPPA;ADCY6;KCNJ2;CACNA2D4;KCNJ4;FOS;ADCY5;PRKAG1;ADCY4;GUCY1B1;CACNA2D2;KCNJ12;CALML6;ADCY7;CACNA1C;PLCB3;KCNJ5;MYLK4;JUN;CACNB1;PIK3R6;ADCY1;CACNA1D;ADCY3;PRKAB2;GUCY1A2;PIK3R5
prerank,Arginine and proline metabolism,-0.2969396608435231,-0.7627511614741382,0.8923076923076924,1.0,1.0,3/48,4.76%,CKMT1A;ARG1;ARG2
prerank,B cell receptor signaling pathway,-0.30653660461511456,-0.7620113211239032,0.8769230769230769,1.0,1.0,34/67,39.11%,CD72;BCL10;NFATC1;CD79B;NFKBIB;CD79A;NFKBIA;CD19;CD22;NFKBIE;PIK3AP1;PPP3R1;CHUK;AKT3;PRKCB;AKT1;KRAS;RASGRP3;VAV1;CARD11;NFATC3;CR2;BLNK;PPP3CC;SOS2;NFATC2;VAV2;MALT1;RELA;NRAS;LYN;GRB2;VAV3;PTPN6
prerank,Alcoholism,-0.28610956740409876,-0.7614375794304402,0.8947368421052632,1.0,1.0,4/90,4.54%,NPY;DRD1;BDNF;FOSB
prerank,Tyrosine metabolism,0.3161413259459207,0.7605313531800026,0.9148936170212766,1.0,1.0,7/27,14.01%,DDC;LRTOMT;PNMT;ALDH3B1;ALDH3A1;ALDH1A3;AOC3
prerank,Pyrimidine metabolism,-0.30563979822695303,-0.7592422825248913,0.8714285714285714,1.0,1.0,23/53,30.72%,NT5C1B;ENTPD8;NME4;NT5C3B;ENTPD5;CMPK2;NT5C2;RRM2B;TK1;ENTPD6;RRM2;UPB1;DHODH;NME1;UMPS;CDA;NT5C;UPP1;CTPS1;NUDT2;NME3;DUT;PNP
prerank,Hepatitis C,-0.27503204973076045,-0.7579938795213036,0.8783783783783784,1.0,1.0,42/130,27.49%,CLDN2;CLDN6;CLDN9;CDKN1A;CLDN4;LDLR;CLDN3;TNF;TICAM1;BAD;MYC;NFKBIA;CYCS;SOCS3;CCND1;CLDN7;CXCL10;BAK1;PPP2CA;BID;EIF2S1;RSAD2;IFNG;CHUK;BAX;AKT3;STAT3;OAS2;E2F2;CLDN23;CLDN8;YWHAE;IRF9;AKT1;KRAS;OAS1;YWHAQ;CASP3;EIF2AK1;CLDN1;MX1;RIPK1
prerank,Bladder cancer,-0.3143378922698541,-0.7552137666485051,0.921875,1.0,1.0,7/41,14.38%,HBEGF;CDKN1A;THBS1;CXCL8;UPK3A;MYC;CCND1
prerank,Arginine biosynthesis,-0.3837366779661153,-0.7522698186624184,0.8275862068965517,1.0,1.0,2/17,4.76%,ARG1;ARG2
prerank,Viral carcinogenesis,-0.27328854416654347,-0.751409927459066,0.9436619718309859,1.0,1.0,68/157,38.90%,GTF2A1L;SRF;EGR3;CDKN1A;EGR2;MAD1L1;BAD;GTF2B;CCR3;NFKBIA;RBL2;CCND1;CDC20;NFKB2;BAK1;CCNE2;GTF2A2;DDX3X;CREB3;VDAC3;GTF2H2;HDAC11;BAX;ATP6V0D1;STAT3;HLA-A;REL;YWHAE;IRF9;CDK1;KRAS;YWHAQ;CASP3;MRPS18B;SKP2;CCND2;TRAF1;YWHAZ;HLA-B;CDK2;SNW1;CCND3;RHOA;CCNA2;HNRNPK;JAK3;EIF2AK2;VAC14;IRF3;MAPKAPK2;CDKN2A;YWHAB;HLA-E;RANBP1;DLG1;SND1;CDK6;SCRIB;CCNE1;TBPL1;RELA;NRAS;MDM2;LYN;KAT2A;GRB2;ATF4;POLB
prerank,Protein processing in endoplasmic reticulum,0.21527803113887972,0.7504869624236035,0.9411764705882353,1.0,1.0,2/159,0.67%,DNAJC5G;TXNDC5
prerank,Circadian rhythm,0.29061053484344357,0.7497321812185106,0.9,1.0,1.0,5/28,17.64%,PRKAG3;PER3;PRKAG1;CSNK1E;PRKAB2
prerank,Lysosome,0.23630650928023353,0.7458243165823869,0.9615384615384616,1.0,1.0,28/118,28.03%,CTSG;ATP6V0D2;CLN3;HYAL1;IDUA;CTSW;NPC1;CTSC;TCIRG1;LIPA;SLC11A1;CTSS;HGSNAT;CTSZ;GM2A;CTSK;CTSA;GLB1;ACP5;ACP2;TPP1;AP3M2;GGA3;ARSB;MANBA;HEXB;LAPTM5;MFSD8
prerank,Fat digestion and absorption,-0.3148513446571575,-0.7440350258499613,0.8142857142857143,1.0,1.0,7/27,15.28%,LIPF;PLA2G1B;PLA2G2D;ACAT2;PLPP2;DGAT2;SLC27A4
prerank,Choline metabolism in cancer,0.23419795573108287,0.7439296162325175,0.9722222222222222,1.0,1.0,23/91,27.75%,DGKB;JMJD7-PLA2G4B;SLC44A4;FOS;DGKE;JUN;PLPP3;SLC44A3;PDGFRA;DGKH;PLD1;GPCPD1;PIP5K1B;SP1;CHPT1;SLC22A4;EGFR;MAPK1;DGKG;PDGFD;DGKA;MAPK9;PIP5K1C
prerank,Steroid hormone biosynthesis,0.28696811508103526,0.7430809251413811,0.8571428571428571,1.0,1.0,9/28,16.95%,LRTOMT;CYP1B1;HSD11B1;UGT2A1;SULT2B1;CYP2E1;HSD17B7;CYP3A5;HSD17B6
prerank,HIF-1 signaling pathway,-0.28023495828710526,-0.7423193828539933,0.9324324324324325,1.0,1.0,20/94,24.12%,EPO;SERPINE1;IL6;CDKN1A;PRKCG;ALDOA;HK2;PFKFB3;GAPDH;ELOC;TFRC;ENO1;EGLN3;LDHA;IFNG;AKT3;PRKCB;STAT3;RPS6;BCL2
prerank,Mitophagy,-0.2969644341598454,-0.74176257454486,0.8870967741935484,1.0,1.0,18/63,26.42%,GABARAP;ATG9A;FIS1;RAB7B;GABARAPL1;CSNK2B;MFN2;TFE3;RRAS;UBB;PGAM5;GABARAPL2;BECN1;FOXO3;ATG5;CSNK2A1;SQSTM1;KRAS
prerank,ErbB signaling pathway,-0.2906320216348097,-0.7410909716411236,0.8529411764705882,1.0,1.0,8/80,12.62%,AREG;HBEGF;CDKN1A;PRKCG;NRG4;ERBB4;BAD;MYC
prerank,Necroptosis,-0.2777352775636097,-0.7399088440734718,0.8888888888888888,1.0,1.0,37/115,30.41%,RNF31;ALOX15;PPID;SPATA2L;IL1A;TNF;IL1B;TICAM1;SLC25A4;TNFRSF10B;SLC25A6;PGAM5;PYCARD;SLC25A5;VDAC3;VDAC2;BID;VDAC1;CHMP2A;IFNG;BAX;STAT3;BCL2;SQSTM1;CHMP1B;IRF9;CAPN1;HSP90AA1;SHARPIN;RIPK1;TNFAIP3;HSP90AB1;PPIA;CHMP4A;CHMP2B;CYLD;VPS4A
prerank,Mucin type O-glycan biosynthesis,0.30271361761065546,0.7351670011114487,0.875,1.0,1.0,11/27,27.50%,GALNT8;ST6GALNAC1;GALNT12;GALNT7;GALNT6;GCNT3;B4GALT5;ST3GAL1;GALNT16;GALNT1;ST3GAL2
prerank,Chagas disease (American trypanosomiasis),-0.28552846871600834,-0.7336581656343164,0.9135802469135802,1.0,1.0,13/98,12.92%,SERPINE1;CCL2;IL6;BDKRB2;CXCL8;TNF;IL2;IL1B;TICAM1;TGFB1;CD3G;NFKBIA;CD3D
prerank,Cortisol synthesis and secretion,-0.2928199823278385,-0.7191738303770847,0.927536231884058,1.0,1.0,6/54,11.74%,CACNA1S;POMC;LDLR;CYP11A1;CYP21A2;KCNK2
prerank,Signaling pathways regulating pluripotency of stem cells,0.22501687409424637,0.7153441914509601,1.0,1.0,1.0,41/117,27.97%,OTX1;POU5F1B;FGFR3;POU5F1;FZD8;WNT9A;WNT3;WNT1;WNT5A;WNT6;WNT10B;WNT16;MAPK11;WNT2;DLX5;INHBB;WNT5B;PCGF3;ACVR1B;TBX3;FZD7;LEFTY2;FZD9;BMP4;BMPR1B;HESX1;PCGF6;FZD4;FZD2;INHBA;WNT10A;SOX2;IGF1;BMPR2;FZD6;MAPK1;MAPK12;MEIS1;ACVR1;FZD1;SMAD5
prerank,Mineral absorption,0.2713860768741232,0.7049278273714036,0.8181818181818182,1.0,1.0,11/44,19.41%,SLC34A2;SLC5A1;ATP1A2;SLC26A3;HEPH;TF;ATP1A3;SLC46A1;MT1E;ATP1A4;SLC30A1
prerank,Th17 cell differentiation,-0.2690827401100457,-0.702155886124281,0.987012987012987,1.0,1.0,38/98,32.95%,IL6;IL23A;IL2;IL1B;IL2RA;NFATC1;TGFB1;HLA-DQA1;NFKBIB;CD3G;IL12RB1;NFKBIA;CD3D;RARA;HLA-DQB1;HLA-DQA2;IL21R;HLA-DOB;NFKBIE;HLA-DRA;PPP3R1;HLA-DRB5;IFNG;CHUK;STAT3;HLA-DPB1;HSP90AA1;HLA-DMA;HSP90AB1;HLA-DMB;IL4R;LCK;NFATC3;HLA-DOA;RXRB;RORC;JAK3;PPP3CC
prerank,AMPK signaling pathway,0.22720757264384692,0.7012354057935537,1.0,1.0,1.0,2/110,2.10%,CFTR;PRKAG3
prerank,Rheumatoid arthritis,-0.27564338439199204,-0.701054723695004,0.9166666666666666,1.0,1.0,33/77,28.60%,CCL2;IL11;IL6;CXCL8;IL23A;IL1A;TNF;ATP6V1C2;IL1B;ATP6V0E2;CD28;TGFB1;HLA-DQA1;TNFSF13;HLA-DQB1;HLA-DQA2;ATP6V1E2;HLA-DOB;LTB;ATP6V0E1;HLA-DRA;ATP6V0B;HLA-DRB5;IFNG;ICAM1;ATP6V0D1;ATP6V1F;HLA-DPB1;ATP6V1C1;HLA-DMA;ATP6V1G1;CCL3L3;HLA-DMB
prerank,Glycolysis / Gluconeogenesis,-0.28235014431992334,-0.6943294815038338,0.9,1.0,1.0,16/51,28.15%,FBP2;ALDOA;HK2;ALDOC;TPI1;GAPDH;ALDH1B1;ENO1;LDHA;PFKP;PCK1;PGM1;LDHB;HKDC1;G6PC3;FBP1
prerank,Longevity regulating pathway,-0.26780573532372487,-0.6928023837178798,0.927536231884058,1.0,1.0,22/94,26.42%,ATG101;KL;CRYAB;HSPA1A;HSPA6;HSPA1B;SESN2;IRS2;HSPA8;PPARGC1A;HSPA2;CREB3;STK11;ADCY2;FOXO3;BAX;AKT3;ATG5;SOD1;RPS6KB2;AKT1;KRAS
prerank,Glutathione metabolism,-0.2792178420849858,-0.6905425038639754,0.8571428571428571,1.0,1.0,18/44,28.69%,GSTT2B;GSTM3;GCLC;TXNDC12;GSTO2;GSTP1;GSTM4;RRM2B;RRM2;GPX4;GPX1;SMS;GSTK1;PGD;GSTO1;GSR;OPLAH;GGCT
prerank,Riboflavin metabolism,-0.3898929446540315,-0.6892638967460776,0.7924528301886793,1.0,1.0,2/8,18.39%,BLVRB;ACP1
prerank,Glioma,-0.2620457576163966,-0.6794124685226778,1.0,1.0,1.0,5/70,7.46%,GADD45A;CDKN1A;CAMK1;PRKCG;GADD45B
prerank,Rap1 signaling pathway,0.20184252554461188,0.6775102081999084,1.0,1.0,1.0,31/187,18.70%,GRIN2B;LPAR4;FGF10;RAPGEF5;NGF;ADCY6;FGFR3;FGF18;MET;EFNA2;ADCY5;ADORA2B;ANGPT4;GRIN2A;ADCY4;PFN4;CALML6;ADCY7;APBB1IP;ITGB2;MAPK11;PLCB3;HGF;ADCY1;DOCK4;ADCY3;FGF7;ITGAM;TEK;ARAP3;PDGFRA
prerank,Synthesis and degradation of ketone bodies,-0.36585523748636883,-0.6747797806900948,0.828125,1.0,1.0,2/9,10.40%,HMGCS1;ACAT2
prerank,Human papillomavirus infection,0.19123980098339868,0.6726686698114345,1.0,1.0,1.0,40/293,18.09%,HES2;SPP1;FN1;ATP6V0D2;HES4;COL1A1;COL6A5;ITGA2;LAMB3;COL1A2;COL4A6;COL6A3;PPP2R2C;FZD8;HES1;RELN;WNT9A;WNT3;WNT1;WNT5A;WNT6;WNT10B;WNT16;HES6;TCIRG1;TNR;COL6A6;CDK4;CREB3L1;ITGA6;WNT2;WNT5B;VWF;ITGA8;CDKN1B;CASP8;FASLG;COL4A1;HLA-G;FZD7
prerank,Transcriptional misregulation in cancer,-0.23416132575509976,-0.6688870361126231,1.0,1.0,1.0,26/154,19.64%,NR4A3;ITGB7;GADD45A;HOXA9;MLF1;IL6;CDKN1A;IL1R2;GADD45B;CXCL8;TLX1;MYC;RARA;DDB2;SIX4;JUP;TFE3;BAK1;PER2;NUPR1;PAX5;HOXA10;ETV7;ETV5;PROM1;ZBTB17
prerank,Thyroid cancer,-0.2828113587226204,-0.6659821722319585,0.921875,1.0,1.0,7/37,16.82%,GADD45A;CDKN1A;GADD45B;MYC;CCND1;DDB2;BAK1
prerank,Base excision repair,-0.295774935415574,-0.6620576220343686,0.9104477611940298,1.0,1.0,16/33,39.12%,MUTYH;POLE4;NTHL1;SMUG1;POLE3;POLD2;TDG;LIG3;OGG1;APEX1;HMGB1;PARP1;XRCC1;POLB;POLL;MPG
prerank,Phagosome,-0.2404863765955495,-0.6612100955397177,0.9875,1.0,1.0,46/136,27.65%,TUBA3D;TUBB8;TUBB2A;CLEC4M;TUBA1B;THBS1;HGS;ATP6V1C2;ATP6V0E2;THBS2;ACTG1;TUBB4B;RAB7B;HLA-DQA1;PLA2R1;TUBA1C;HLA-DQB1;HLA-DQA2;ATP6V1E2;STX12;HLA-DOB;ITGA5;ATP6V0E1;ACTB;HLA-DRA;TFRC;TAP1;CYBA;CORO1A;ATP6V0B;CALR;RILP;HLA-DRB5;CD209;ATP6V0D1;TUBA4A;HLA-A;ATP6V1F;HLA-DPB1;SFTPD;ATP6V1C1;TUBB6;RAB5C;HLA-DMA;TUBA1A;ATP6V1G1
prerank,TGF-beta signaling pathway,-0.25804481270363233,-0.6605475546261131,0.9855072463768116,1.0,1.0,10/84,12.91%,BMP2;INHBC;GDF7;AMH;THBS1;TNF;NOG;TGFB1;MYC;TGIF2
prerank,Toxoplasmosis,-0.23966903261855832,-0.6578237371744341,0.9875,1.0,1.0,32/108,27.55%,HSPA1A;LDLR;HSPA6;TNF;TGFB1;BAD;HLA-DQA1;HSPA1B;NFKBIB;NFKBIA;CYCS;HLA-DQB1;HSPA8;CD40LG;MAP2K3;HLA-DQA2;IL12B;HSPA2;HLA-DOB;HLA-DRA;HLA-DRB5;IFNG;CHUK;AKT3;STAT3;BCL2;CD40;HLA-DPB1;AKT1;IL10RB;CASP3;HLA-DMA
prerank,Hippo signaling pathway,-0.23811066303614437,-0.6548659955112547,0.9878048780487805,1.0,1.0,20/150,15.01%,SERPINE1;AREG;CTNNA3;BMP2;CCN2;GDF7;PRKCZ;LLGL1;PARD6B;AMH;BIRC5;PARD6A;FZD10;WNT7B;ACTG1;TGFB1;MYC;LATS2;CCND1;TP53BP2
prerank,MicroRNAs in cancer,-0.22740357495404923,-0.6519778253822034,0.9859154929577465,1.0,1.0,7/152,8.07%,MIR27B;MIR26B;TNN;MIR199A1;CDKN1A;PRKCG;THBS1
prerank,SNARE interactions in vesicular transport,-0.29301425178484836,-0.6501886392974533,0.9682539682539683,1.0,1.0,18/33,41.44%,STX11;USE1;VAMP5;VAMP8;STX10;STX5;VTI1A;VAMP2;VAMP1;YKT6;GOSR2;STX7;STX8;VAMP3;VAMP7;SEC22B;STX4;BNIP1
prerank,Pertussis,-0.2643777318130457,-0.6490567034379374,0.971830985915493,1.0,1.0,16/70,18.73%,C4BPB;C4B;IL6;CXCL8;IL23A;IL1A;TNF;IL1B;TICAM1;IRF8;CFL2;IL12B;IRF1;CFL1;PYCARD;ITGA5
prerank,Pathways in cancer,0.17612828849850723,0.649039306521975,1.0,1.0,1.0,85/474,19.69%,FN1;DCC;KNG1;LPAR4;PTGER1;NTRK1;RXRG;GNG10;PTGER3;HHIP;RET;FGF10;ITGA2;BDKRB1;AGT;LAMB3;MMP1;GNG8;COL4A6;ADCY6;FGFR3;FZD8;HES1;EGLN1;BIRC7;FGF18;FOS;MET;WNT9A;WNT3;ADCY5;WNT1;CDKN2B;EDN1;WNT5A;ADCY4;EDNRA;WNT6;DLL1;AGTR1;WNT10B;IL12A;WNT16;TGFA;CALML6;ADCY7;RASGRP4;PLCB3;CXCL12;HGF;MMP2;FRAT1;CDK4;SUFU;ITGA6;WNT2;JUN;ADCY1;NOS2;KLK3;ALK;WNT5B;IL7R;ADCY3;FGF7;CDKN1B;CASP8;RUNX1;VHL;FASLG;IL4;AR;CSF3R;COL4A1;FZD7;TRAF4;ARNT2;PDGFRA;PLD1;LAMA3;LPAR6;GLI2;IKBKB;LAMA2;FZD9
prerank,Fanconi anemia pathway,0.237519896410218,0.6429361235905352,0.9714285714285714,1.0,1.0,13/49,24.13%,FANCA;EME1;PMS2;HES1;FANCB;PALB2;FAAP24;POLI;FANCE;TOP3A;FANCM;ATR;RAD51
prerank,RNA transport,0.19434839958660804,0.6428045898709027,1.0,1.0,1.0,5/151,5.68%,POM121L2;EIF1AY;EIF4EBP3;PRMT5;SNORD3A
prerank,Human immunodeficiency virus 1 infection,-0.21967843840259668,-0.6399008436748872,1.0,1.0,1.0,74/184,37.93%,PRKCG;GNG4;CCNB2;APOBEC3D;APOBEC3B;TNF;WEE1;NFATC1;BAD;CD3G;NFKBIA;CYCS;CD3D;CFL2;MAP2K3;APOBEC3A;APOBEC3H;APOBEC3F;SKP1;ELOC;BAK1;AP1M2;CFL1;TAP1;BID;PPP3R1;CALR;AP1S3;CHUK;BAX;AKT3;PRKCB;APOBEC3C;BCL2;HLA-A;RPS6KB2;CDK1;AKT1;KRAS;GNB5;CASP3;RIPK1;AP1S1;B2M;LIMK2;CCNB1;NFATC3;HLA-B;ITPR1;ELOB;DCAF1;GNB3;CRK;RNF7;CDC25C;GNG12;PPP3CC;GNAI3;IRF3;BST2;TRIM5;MAPK8;HLA-E;CALM1;NFATC2;GNG2;AP1S2;RBX1;GNG7;RELA;NRAS;TBK1;TAB2;MAPK10
prerank,Fatty acid degradation,0.22752728303174574,0.6336557163731137,0.9142857142857143,1.0,1.0,2/38,6.08%,CYP4A11;ACSBG2
prerank,Salmonella infection,-0.23948396760965895,-0.6302430480209574,1.0,1.0,1.0,24/81,29.58%,IL6;CXCL8;IL1A;IL1B;ACTG1;RAB7B;MYH14;PFN1;CXCL2;WASF2;RHOG;PYCARD;ACTB;FLNC;RILP;IFNG;ARPC5L;FLNA;CCL4;CCL4L2;CCL3L3;PFN2;WASL;ARPC3
prerank,Melanoma,-0.2401135830784861,-0.6257184107858261,0.9692307692307692,1.0,1.0,9/62,16.82%,GADD45A;CDKN1A;GADD45B;BAD;CCND1;DDB2;FGF9;FGF17;BAK1
prerank,Vasopressin-regulated water reabsorption,0.24169337109872163,0.6206407077371937,0.96875,1.0,1.0,13/40,30.00%,ADCY6;AQP4;AQP3;CREB3L1;DYNC1I1;ADCY3;CREB3L2;ADCY9;CREB5;DYNC2H1;NSF;DYNLL2;AVPR2
prerank,"Valine, leucine and isoleucine degradation",0.23063771939629002,0.6182249648813158,0.9705882352941176,1.0,1.0,4/46,10.88%,BCKDHA;BCAT1;OXCT2;MCEE
prerank,Leukocyte transendothelial migration,-0.22809328397320208,-0.6152170660516678,0.9873417721518988,1.0,1.0,7/101,8.75%,CLDN2;CLDN6;CTNNA3;CLDN9;PRKCG;CLDN4;CLDN3
prerank,Sulfur metabolism,-0.30766594237747674,-0.6103414607719562,0.8727272727272727,1.0,1.0,4/8,36.12%,ETHE1;MPST;TST;PAPSS2
prerank,RIG-I-like receptor signaling pathway,-0.2606644480426136,-0.6094244386950992,0.9705882352941176,1.0,1.0,12/51,24.02%,CXCL8;TNF;ISG15;PIN1;NFKBIB;NFKBIA;IL12B;CXCL10;DDX3X;DHX58;CHUK;ATG5
prerank,Glycerophospholipid metabolism,0.2019326643975833,0.6075530885905458,1.0,1.0,1.0,4/84,6.97%,DGKB;JMJD7-PLA2G4B;PLA2G3;PLA2G10
prerank,Osteoclast differentiation,-0.22794498400359853,-0.6060605047839992,0.9873417721518988,1.0,1.0,16/121,15.37%,FOSL1;FOSB;FHL2;LILRA1;JUND;IL1A;TNF;FOSL2;RELB;IL1B;NFATC1;TGFB1;NFKBIA;SOCS3;TNFRSF11B;NFKB2
prerank,Tuberculosis,-0.2207855471157396,-0.6034665672316284,1.0,1.0,1.0,44/154,27.56%,CAMP;IL6;CLEC4M;CR1;IL23A;IL1A;TNF;IL1B;BCL10;TGFB1;BAD;HLA-DQA1;PLA2R1;CYCS;CLEC4E;HLA-DQB1;HLA-DQA2;IL12B;PLK3;HLA-DOB;SPHK1;HLA-DRA;CORO1A;ATP6V0B;BID;PPP3R1;HLA-DRB5;CD209;IFNG;LSP1;NFYA;BAX;ATP6V0D1;RFXANK;AKT3;BCL2;HSPD1;HLA-DPB1;AKT1;IL10RB;CASP3;RAB5C;HLA-DMA;RIPK2
prerank,T cell receptor signaling pathway,-0.22859504450260193,-0.6019951454939352,1.0,1.0,1.0,42/93,39.11%,TNF;IL2;BCL10;CD28;NFATC1;NFKBIB;CD3G;NFKBIA;CD3D;CD40LG;NFKBIE;MAP3K14;PPP3R1;IFNG;CHUK;AKT3;TEC;MAP3K8;AKT1;KRAS;VAV1;CARD11;PDCD1;LCK;NFATC3;CD8B;RHOA;PPP3CC;SOS2;ICOS;NFATC2;IL10;VAV2;DLG1;PRKCQ;MALT1;RELA;NRAS;NCK1;GRB2;VAV3;PTPN6
prerank,Epithelial cell signaling in Helicobacter pylori infection,-0.2508931587823573,-0.6000674834129732,0.9583333333333334,1.0,1.0,20/61,27.65%,HBEGF;CXCR2;CXCL8;ATP6V1C2;ATP6V0E2;NFKBIA;ATP6V1E2;JAM3;ATP6V0E1;MAP3K14;NOD1;ATP6V0B;ADAM17;CHUK;ATP6V0D1;CSK;ATP6V1F;ATP6V1C1;CASP3;ATP6V1G1
prerank,Endocrine and other factor-regulated calcium reabsorption,-0.255383005558594,-0.5992550316776258,0.9420289855072463,1.0,1.0,8/44,17.32%,KL;BDKRB2;PRKCG;ESR1;FXYD2;ATP1B1;ATP1B2;AP2S1
prerank,Staphylococcus aureus infection,0.22352977933832152,0.5988198476405779,1.0,1.0,1.0,14/50,21.28%,FCGR3B;FPR2;FPR3;DEFB1;C3AR1;CFI;ITGB2;CFH;FCGR2B;FCGR3A;ITGAM;KRT10;C1S;C5
prerank,Gastric cancer,0.17438484714342803,0.5942294929188433,1.0,1.0,1.0,21/126,16.87%,RXRG;FGF10;ABCB1;FZD8;SHC4;FGF18;MET;WNT9A;WNT3;WNT1;CDKN2B;WNT5A;WNT6;WNT10B;WNT16;HGF;FRAT1;WNT2;WNT5B;FGF7;CDKN1B
prerank,VEGF signaling pathway,0.20829836295038626,0.5908152948940315,0.975609756097561,1.0,1.0,1/54,1.48%,JMJD7-PLA2G4B
prerank,Small cell lung cancer,0.1987688447561397,0.5904575376026594,1.0,1.0,1.0,17/90,20.56%,FN1;RXRG;ITGA2;LAMB3;COL4A6;BIRC7;CDKN2B;CDK4;ITGA6;NOS2;CDKN1B;COL4A1;TRAF4;LAMA3;IKBKB;LAMA2;TRAF5
prerank,Regulation of actin cytoskeleton,0.17162780620359405,0.5778229059101323,1.0,1.0,1.0,24/189,18.70%,FN1;KNG1;LPAR4;FGF10;ITGA2;BDKRB1;MYLK3;MYLK2;FGFR3;FGF18;SCIN;PFN4;ITGB2;CXCL12;CHRM3;MYLK4;ITGA6;ITGA8;FGF7;MYL7;SSH1;ITGAM;MYH10;PDGFRA
prerank,Terpenoid backbone biosynthesis,-0.28720282246700857,-0.5751019013476714,0.90625,1.0,1.0,12/20,41.86%,HMGCS1;ACAT2;PDSS2;PMVK;FNTB;MVK;IDI1;RCE1;FDPS;DHDDS;FNTA;HMGCR
prerank,Endocytosis,-0.1947725737795241,-0.5718681108262699,1.0,1.0,1.0,78/238,33.23%,PRKCZ;CXCR2;FOLR3;PARD6B;HSPA1A;HGS;LDLR;HSPA6;PARD6A;RAB8A;GRK1;IL2RA;GRK4;HSPA1B;CAV1;HSPA8;VPS37B;FOLR1;CBLC;CAPZB;FGFR4;HSPA2;AP2S1;UBB;RAB11FIP1;GRK6;PARD3;SNX3;TFRC;SH3GL2;SNX2;AP2M1;MVB12A;WASHC1;VPS25;SNF8;CHMP2A;CAV2;WIPF3;PRKCI;ARPC5L;ARF6;RAB35;RAB4A;RAB11FIP4;AGAP1;HLA-A;VPS28;CHMP1B;CLTA;RNF41;FGFR2;RAB11B;RAB5C;EHD3;NEDD4L;EHD4;SNX5;CHMP4A;CHMP2B;WASL;ARPC3;VPS4A;HLA-B;ITCH;VPS35;CLTCL1;RHOA;GRK2;KIF5B;SNX4;ARF3;RAB11FIP3;VPS37C;WWP1;ARPC5;BIN1;CAPZA1
prerank,Proximal tubule bicarbonate reclamation,0.2382545059085708,0.5650070951573704,0.9782608695652174,1.0,1.0,5/20,17.97%,ATP1A2;ATP1A3;AQP1;GLUD2;ATP1A4
prerank,Proteoglycans in cancer,-0.19829283808116208,-0.5647470478620424,1.0,1.0,1.0,42/184,26.42%,IHH;HBEGF;CDKN1A;PRKCG;THBS1;PLAUR;TNF;ESR1;ERBB4;FZD10;WNT7B;ACTG1;TGFB1;SDC4;MYC;CAV1;HSPB2;EZR;CCND1;IL12B;ELK1;RRAS;SLC9A1;PDCD4;ITGA5;ACTB;FLNC;WNT2B;TIMP3;EIF4B;CD63;CAV2;AKT3;PRKCB;STAT3;RPS6;WNT4;FLNA;RPS6KB2;AKT1;PPP1R12C;KRAS
prerank,Protein export,-0.2655446020678047,-0.5641783048318612,0.96875,1.0,1.0,23/23,73.48%,IMMP2L;SRP19;SEC11A;SRP14;SPCS1;SEC61B;SRP54;OXA1L;SRPRB;SEC61A2;SEC11C;SPCS2;SRPRA;SRP9;SPCS3;SRP72;SEC63;SEC61A1;SEC62;SEC61G;SRP68;IMMP1L;HSPA5
prerank,AGE-RAGE signaling pathway in diabetic complications,-0.20664462103424358,-0.5636309582050405,1.0,1.0,1.0,13/98,14.38%,SERPINE1;CCL2;IL6;PRKCZ;CXCL8;IL1A;TNF;IL1B;PIM1;NFATC1;TGFB1;VEGFD;CCND1
prerank,Pantothenate and CoA biosynthesis,0.25235777102507795,0.5601295369585386,0.9302325581395349,1.0,1.0,1/16,4.89%,BCAT1
prerank,Ascorbate and aldarate metabolism,0.2600308304221854,0.5568154738320646,0.9166666666666666,1.0,1.0,1/10,7.02%,UGT2A1
prerank,N-Glycan biosynthesis,0.19924614537040078,0.5565183757939126,1.0,1.0,1.0,19/48,37.40%,TUSC3;ALG12;RPN2;MAN2A2;FUT8;ALG6;MAN1A1;MGAT4A;ST6GAL2;STT3B;DOLPP1;ALG11;ALG2;MOGS;DOLK;RPN1;GANAB;B4GALT2;ALG9
prerank,Sulfur relay system,-0.31500833135325523,-0.5551506915167125,0.8870967741935484,1.0,1.0,5/8,30.69%,URM1;CTU2;MPST;MOCS2;TST
prerank,Hepatocellular carcinoma,-0.19484021270557703,-0.5509546452022465,1.0,1.0,1.0,20/151,15.52%,GADD45A;CDKN1A;CSNK1A1L;PRKCG;GADD45B;GSTT2B;GSTM3;FZD10;WNT7B;ACTG1;TGFB1;BAD;MYC;TERT;GSTO2;CCND1;GSTP1;GSTM4;DDB2;ELK1
prerank,Phosphatidylinositol signaling system,0.17901437693064542,0.5490579465579417,1.0,1.0,1.0,8/90,14.95%,DGKB;MTMR7;PLCD3;INPP5B;CALML6;PLCB3;DGKE;MTMR3
prerank,Prostate cancer,-0.20687122795880225,-0.5474676560485194,1.0,1.0,1.0,20/91,29.08%,CDKN1A;NKX3-1;IL1R2;BAD;NFKBIA;CCND1;GSTP1;CCNE2;CREB3;ETV5;CHUK;AKT3;BCL2;E2F2;AKT1;HSP90AA1;KRAS;FGFR2;HSP90AB1;PDGFC
prerank,Basal cell carcinoma,-0.21739624276842248,-0.5427317235652122,0.9696969696969697,1.0,1.0,7/56,12.01%,GADD45A;BMP2;CDKN1A;GADD45B;FZD10;WNT7B;GLI1
prerank,Insulin resistance,0.17446344228716487,0.5337047472832642,1.0,1.0,1.0,2/99,2.10%,SLC27A6;PRKAG3
prerank,Leishmaniasis,-0.21813360408926066,-0.5299184818308624,1.0,1.0,1.0,19/71,23.62%,CR1;IL1A;TNF;IL1B;TGFB1;HLA-DQA1;NFKBIB;NFKBIA;HLA-DQB1;HLA-DQA2;IL12B;ELK1;HLA-DOB;MARCKSL1;HLA-DRA;CYBA;HLA-DRB5;IFNG;PRKCB
prerank,Primary bile acid biosynthesis,-0.28436222259192867,-0.5286504390298267,0.9444444444444444,1.0,1.0,2/14,8.08%,AMACR;CYP8B1
prerank,PI3K-Akt signaling pathway,-0.18072378240594153,-0.5271538333107696,1.0,1.0,1.0,27/303,13.69%,EPO;CSF3;ITGB7;TNN;AREG;BDNF;NTF4;TCL1A;IL6;CDKN1A;EPHA2;EFNA1;GNG4;THBS1;IL2;IL2RA;THBS2;ERBB4;LPAR3;BAD;COL9A1;MYC;VEGFD;IL3RA;RBL2;ITGA2B;MCL1
prerank,Lysine degradation,-0.22439805250908734,-0.5270376035588803,1.0,1.0,1.0,30/57,46.21%,ACAT2;ALDH1B1;HYKK;TMLHE;SETD3;DOT1L;ECHS1;HADHA;DHTKD1;ASH1L;SUV39H2;HADH;BBOX1;COLGALT2;KMT5A;PRDM2;DLST;SETDB1;DLD;EHHADH;ALDH2;GCDH;SETD1B;EHMT2;SETD2;PIPOX;ALDH3A2;ALDH7A1;KMT5C;SUV39H1
prerank,Kaposi sarcoma-associated herpesvirus infection,-0.1899585112328699,-0.5255787695008934,1.0,1.0,1.0,34/159,27.11%,RCAN1;IL6;CDKN1A;GNG4;CXCL8;GABARAP;TICAM1;NFATC1;MYC;CCR3;NFKBIA;CYCS;GABARAPL1;CXCL2;CCND1;BAK1;UBB;GABARAPL2;BECN1;BID;PPP3R1;CHUK;ICAM1;BAX;AKT3;ZFP36;STAT3;E2F2;HLA-A;IRF9;AKT1;KRAS;GNB5;CASP3
prerank,Fluid shear stress and atherosclerosis,-0.19503801272428303,-0.5227170626256861,1.0,1.0,1.0,31/125,26.81%,CCL2;PRKCZ;IL1R2;IL1A;TNF;GSTT2B;IL1B;GSTM3;ACTG1;SDC4;ITGA2B;CAV1;GSTO2;GSTP1;GSTM4;ACTB;TXN2;ASS1;CYBA;MAP2K5;CAV2;IFNG;CHUK;ICAM1;AKT3;BCL2;SQSTM1;SUMO2;AKT1;HSP90AA1;SUMO1
prerank,"Alanine, aspartate and glutamate metabolism",0.21551791390986544,0.5210745087518855,0.9428571428571428,1.0,1.0,6/28,17.59%,NAT8L;ASNS;GPT;RIMKLB;GLUD2;GPT2
prerank,Herpes simplex virus 1 infection,0.1406176424716707,0.5186502527735217,1.0,1.0,1.0,97/449,24.57%,ZNF99;ZNF337;ZNF223;ZNF233;ZNF90;ZNF285;CGAS;ZNF613;ZNF354C;ZNF30;ZNF564;ZNF718;ZNF343;ZNF777;IL12A;ZNF17;ZNF20;ZNF727;ZNF571;OAS3;ZNF404;ZNF442;SRSF9;ZNF780A;ZNF709;ZNF785;ZNF764;ZNF610;ZNF334;ZNF33A;ZNF551;ZNF436;ZNF304;ZNF627;ZNF620;ZNF600;ZNF44;ZNF74;ZNF605;ZNF850;CASP8;ZNF682;ZNF254;FASLG;ZNF658;ZNF510;ZNF615;ZNF107;HLA-G;ZFP1;ZNF624;ZNF736;ZFP90;POU2F3;ZNF205;ZFP69;ZNF799;ZNF34;ZNF169;EIF2AK3;ZNF567;IKBKB;ZNF845;ZNF585B;ZNF418;ZNF286A;ZNF763;TRAF5;ZNF813;ZNF737;ZNF470;ZNF607;ZNF879;C5;ZNF585A;ZFP37;ZNF891;ZNF486;ZNF222;ZNF282;ZNF230;ZNF181;ZNF534;ZNF772;IFNGR1;ZNF766;ZNF675;ZNF268;ZNF558;ZNF569;ZFP57;ZFP69B;ZNF133;ZNF251;ZNF284;C3;ZNF200
prerank,Propanoate metabolism,0.1988547992056149,0.5185937458931483,1.0,1.0,1.0,2/29,10.88%,BCKDHA;MCEE
prerank,FoxO signaling pathway,-0.1877011279366646,-0.5155396012960791,1.0,1.0,1.0,33/124,29.10%,GADD45A;IL6;CDKN1A;GADD45B;CCNB2;GABARAP;PLK1;SLC2A4;TGFB1;GABARAPL1;RBL2;IRS2;CCND1;PLK3;GABARAPL2;HOMER2;STK11;PRMT1;PLK4;NLK;CHUK;FOXO3;AKT3;STAT3;FBXO32;S1PR4;PCK1;AKT1;KRAS;G6PC3;FBXO25;SKP2;CCND2
prerank,Amino sugar and nucleotide sugar metabolism,0.18469838521538862,0.5130159123023146,1.0,1.0,1.0,5/46,16.17%,CHIT1;HK3;CYB5RL;GALE;NPL
prerank,Thyroid hormone signaling pathway,-0.18481528541094616,-0.509710399374933,1.0,1.0,1.0,24/110,26.93%,DIO1;RCAN1;PRKCG;ESR1;ACTG1;FXYD2;BAD;DIO2;MYC;ATP1B1;CCND1;PFKFB2;ATP1B2;SLC9A1;ACTB;MED30;PFKP;AKT3;PRKCB;WNT4;AKT1;KRAS;THRA;PLCB4
prerank,Fc gamma R-mediated phagocytosis,-0.19025986603097614,-0.5082811188184773,1.0,1.0,1.0,44/85,45.15%,PRKCG;PLPP2;CFL2;WASF2;SPHK1;CFL1;MARCKSL1;ARPC5L;ARF6;AKT3;PRKCB;PRKCE;RPS6KB2;AKT1;PLA2G6;WASF3;LIMK2;VAV1;WASL;ARPC3;CRK;VASP;ARPC5;BIN1;ARPC2;VAV2;PIP5K1A;ARPC4;LYN;VAV3;DNM2;PIK3CA;GSN;PIK3CB;RAC2;ASAP2;DOCK2;PLA2G4F;INPP5D;LIMK1;NCF1;RAF1;SYK;FCGR1A
prerank,Nucleotide excision repair,-0.21080653929708137,-0.4957423726360689,0.9848484848484849,1.0,1.0,18/43,37.08%,ERCC5;DDB2;POLE4;CETN2;RFC2;RPA3;GTF2H2;POLE3;RAD23A;POLD2;RPA2;ERCC1;CCNH;RFC5;ERCC2;RFC4;RBX1;XPA
prerank,Peroxisome,0.16607922119643895,0.4953264118119811,1.0,1.0,1.0,15/77,21.84%,DHRS4L1;XDH;BAAT;NUDT7;FAR2;NOS2;ABCD2;PEX1;PEX12;NUDT12;ACSL5;HMGCLL1;ACAA1;IDH1;MLYCD
prerank,Thermogenesis,-0.17626981561389116,-0.49383869780284506,1.0,1.0,1.0,64/206,30.64%,ADCY10;COX6B2;COX20;NDUFA7;ACTG1;COX4I1;NDUFC2;NDUFA4L2;ATP5MC2;NDUFAF3;ATP5MC1;NDUFS8;MAP2K3;PPARGC1A;NDUFA12;COX7A2L;COX8A;NDUFB11;SLC25A29;NDUFB7;NDUFB9;COA1;ATP5PO;COX4I2;CREB3;BMP8A;ACTB;COX5A;COX6A1;NDUFAF2;UQCRFS1;ADCY2;NDUFB10;RPS6KA6;NDUFAB1;COX5B;PNPLA2;NDUFB5;CYC1;UQCRH;COA4;NDUFAF4;COA7;NDUFB8;RPS6;ATP5PD;ATP5MC3;RPS6KB2;COX14;KRAS;ATP5F1C;ATP5MG;FRS2;NDUFS6;KDM3A;NDUFA10;SDHB;NDUFS4;UQCRB;COA6;ATP5F1A;NDUFV2;UQCRC1;COA3
prerank,Acute myeloid leukemia,-0.19265314021899158,-0.4899508431689749,1.0,1.0,1.0,15/62,26.42%,PIM1;BAD;MYC;RARA;CCND1;JUP;PER2;KIT;CHUK;BCL2A1;AKT3;STAT3;RPS6KB2;AKT1;KRAS
prerank,Glyoxylate and dicarboxylate metabolism,-0.21270560533811816,-0.4863707381828904,0.9846153846153847,1.0,1.0,11/26,41.03%,ACAT2;MDH2;AMT;GCSH;GLDC;CS;ACO1;DLD;GRHPR;SHMT2;CAT
prerank,One carbon pool by folate,0.2001845130248739,0.4777822717468634,0.9722222222222222,1.0,1.0,1/19,4.16%,TYMS
prerank,Adherens junction,-0.18302615374287343,-0.4772881732546666,1.0,1.0,1.0,13/70,24.81%,CTNNA3;SNAI1;ACTG1;NECTIN2;CSNK2B;WASF2;ACP1;PARD3;ACTB;NLK;VCL;CTNND1;CSNK2A1
prerank,Toll-like receptor signaling pathway,0.15173457608622623,0.4700169951487224,1.0,1.0,1.0,26/84,29.78%,SPP1;TLR8;TIRAP;FOS;IL12A;MAPK11;CD80;JUN;CD14;CASP8;TLR5;IKBKB;CXCL11;CTSK;TLR6;MAPK1;MAPK12;TLR4;TLR2;MAPK9;MAPK3;MAPK13;MAP2K6;CD86;TRAF3;CCL3
prerank,Other glycan degradation,0.2125276415729257,0.4585327714885983,0.9761904761904762,1.0,1.0,16/16,78.76%,ENGASE;GLB1;MANBA;HEXB;GBA2;MAN2C1;FUCA2;MAN2B2;NEU3;HEXD;FUCA1;HEXA;MAN2B1;NEU1;AGA;NEU4
prerank,Aminoacyl-tRNA biosynthesis,0.19226700009618153,0.455196434906893,1.0,1.0,1.0,24/24,80.80%,CARS2;SEPSECS;TARS2;MARS2;HARS2;MTFMT;QRSL1;AARS2;PARS2;GATC;EARS2;IARS2;PSTK;LARS2;NARS2;FARSB;YARS2;RARS2;SARS2;FARSA;DARS2;WARS2;FARS2;GATB
prerank,Breast cancer,-0.16393513763999293,-0.4538063638963156,1.0,1.0,1.0,18/131,16.82%,GADD45A;CDKN1A;CSNK1A1L;GADD45B;DLL3;ESR1;BRCA2;PGR;FZD10;WNT7B;MYC;HES5;CCND1;DDB2;NFKB2;FGF9;FGF17;BAK1
prerank,Starch and sucrose metabolism,-0.20871325497259768,-0.44905562517552944,1.0,1.0,1.0,12/27,39.50%,GYG2;HK2;TREH;PGM1;HKDC1;G6PC3;GCK;GYG1;GBE1;PGM2;PYGM;HK1
prerank,TNF signaling pathway,-0.17297477924548646,-0.44365398304195636,1.0,1.0,1.0,30/103,31.75%,CCL2;IL6;LIF;TNF;IL1B;NFKBIA;SOCS3;CXCL2;MAP2K3;BCL3;IRF1;CXCL10;PGAM5;CREB3;MAP3K14;BAG4;CHUK;ICAM1;AKT3;LTA;MAP3K8;AKT1;CASP3;RIPK1;TNFAIP3;JUNB;TRAF1;ITCH;TAB3;CCL5
prerank,Notch signaling pathway,0.16553369383123373,0.4249478119403397,1.0,1.0,1.0,4/46,11.59%,DTX4;PSEN2;HES1;DLL1
prerank,Human cytomegalovirus infection,-0.14893603650174111,-0.41756683986934556,1.0,1.0,1.0,45/196,28.07%,CCL2;IL6;CDKN1A;CXCR2;PRKCG;GNG4;CXCL8;TNF;IL1B;NFATC1;MYC;CCR3;NFKBIA;CYCS;CCND1;ELK1;BAK1;CREB3;TAP1;ADCY2;BID;PPP3R1;AKAP13;CALR;CHUK;BAX;AKT3;PRKCB;STAT3;E2F2;HLA-A;RPS6KB2;CCL4;AKT1;KRAS;GNB5;CCL4L2;PTGER2;PLCB4;IL10RB;CASP3;ARHGEF11;RIPK1;B2M;CCL3L3
prerank,Insulin signaling pathway,-0.14600001121173914,-0.41018286335807913,1.0,1.0,1.0,46/125,38.49%,FBP2;PRKCZ;SLC2A4;BAD;HK2;IRS2;SOCS3;PPP1R3F;PPARGC1A;ELK1;INPP5K;PRKCI;AKT3;ACACA;RPS6;PPP1R3B;PCK1;RPS6KB2;AKT1;KRAS;HKDC1;G6PC3;FBP1;MKNK2;RAPGEF1;GCK;SHC2;CRK;SHC1;TSC1;INSR;SOS2;PPP1CC;MAPK8;PHKA2;CALM1;PCK2;FLOT2;PPP1CB;FLOT1;EIF4EBP1;PTPN1;NRAS;MAPK10;PYGM;GRB2
prerank,Ribosome biogenesis in eukaryotes,-0.1558346888594525,-0.4074421556844608,1.0,1.0,1.0,35/72,41.45%,NXT2;CSNK2B;RRP7A;RAN;EIF6;SBDS;SNU13;WDR43;IMP4;RCL1;POP5;CSNK2A1;FBL;RPP40;NVL;NOP10;MDN1;NXT1;TBL3;UTP18;POP7;POP4;EFL1;RPP25;GNL2;RPP30;REXO2;RPP25L;EMG1;NOP56;NHP2;RBM28;NMD3;NOB1;NXF1
prerank,Aldosterone-regulated sodium reabsorption,-0.17401635809051527,-0.39507985666396717,1.0,1.0,1.0,9/33,27.66%,PRKCG;FXYD2;ATP1B1;ATP1B2;SCNN1B;KCNJ1;PRKCB;KRAS;NEDD4L
prerank,DNA replication,0.15057604653217752,0.38989557102064365,1.0,1.0,1.0,8/34,22.33%,POLD1;PRIM1;PRIM2;DNA2;POLE;POLD4;MCM6;RNASEH1
prerank,Renal cell carcinoma,-0.14407934690012128,-0.37769620457289294,1.0,1.0,1.0,28/65,42.25%,CDKN1A;TGFB1;BAD;TFE3;ELOC;EGLN3;PRCC;AKT3;RAP1B;AKT1;KRAS;RAPGEF1;ELOB;CRK;PTPN11;SOS2;TGFB2;SLC2A1;RBX1;NRAS;CUL2;GRB2;HIF1A;ETS1;VEGFA;BRAF;PIK3CA;PIK3CB
prerank,Oocyte meiosis,-0.1425189443820661,-0.3716873310882799,1.0,1.0,1.0,42/105,37.15%,SMC1B;CCNB2;PGR;PLK1;MAD1L1;MAD2L2;CDC20;MAD2L1;ANAPC11;SKP1;CCNE2;STAG3;PPP2CA;ADCY2;PPP3R1;RPS6KA6;SGO1;YWHAE;ANAPC5;CDK1;ANAPC2;YWHAQ;ANAPC10;CCNB1;YWHAZ;FBXO5;ITPR1;CDK2;PPP2R1A;ANAPC13;SLK;CDC25C;PPP3CC;PPP2R5C;PPP1CC;YWHAB;PPP2R1B;CALM1;AURKA;CCNE1;RBX1;PPP1CB
prerank,Other types of O-glycan biosynthesis,-0.17589921138680514,-0.3607617021947621,1.0,1.0,1.0,22/22,82.43%,GXYLT2;ST6GAL1;B4GALT1;B3GLCT;COLGALT2;ST3GAL3;B4GALT3;OGT;POGLUT1;POMT1;RFNG;POFUT2;MFNG;GXYLT1;PLOD3;B4GALT2;POFUT1;ST6GAL2;LFNG;POMT2;COLGALT1;EOGT
prerank,Neurotrophin signaling pathway,-0.1311143466322096,-0.3491157820353776,1.0,1.0,1.0,34/114,34.24%,BDNF;NTF4;BAD;NFKBIB;NFKBIA;NTRK2;BEX3;NFKBIE;ARHGDIG;MAP2K5;ZNF274;RPS6KA6;SH2B3;FOXO3;BAX;AKT3;BCL2;RAP1B;YWHAE;AKT1;KRAS;RIPK2;FRS2;ARHGDIA;RAPGEF1;SHC2;RHOA;CRK;SHC1;ARHGDIB;PTPN11;SOS2;MAPKAPK2;MAPK8
prerank,Inositol phosphate metabolism,0.10836077431713727,0.32211862598782337,1.0,0.9998946148171567,1.0,10/70,21.37%,MTMR7;PLCD3;INPP5B;PLCB3;PLCH2;MTMR3;INPP4A;PIP5K1B;PIP5KL1;PLCE1
prerank,mTOR signaling pathway,-0.11393824313402091,-0.30333442771771807,1.0,0.9999524058826329,1.0,57/142,39.23%,PRKCG;TNF;ATP6V1C2;FZD10;WNT7B;SESN2;LAMTOR1;ATP6V1E2;LAMTOR4;STK11;WNT2B;DEPTOR;RPS6KA6;EIF4B;CASTOR2;CHUK;AKT3;PRKCB;RPS6;SLC3A2;ATP6V1F;WNT4;RPS6KB2;AKT1;RRAGA;KRAS;ATP6V1C1;ATP6V1G1;SKP2;FNIP1;LAMTOR5;ATP6V1D;RRAGB;RHOA;LAMTOR2;SEC13;ATP6V1G2;MAPKAP1;TSC1;RRAGC;INSR;SOS2;RRAGD;DVL3;FZD5;SLC7A5;FZD3;MLST8;EIF4EBP1;LRP6;ATP6V1A;TTI1;NRAS;AKT1S1;GRB2;CAB39L;ATP6V1E1
